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Abstract
I. Selective chlorination and fluorination of quinols
II. Synthetic study of strongylophorine-26
by
Sihan Li
Advisor: Dr. Shengping Zheng
Organic compounds containing halogen are an important and useful class of intermediates that
can be converted to other functionalities. This thesis describes our strategy in selective
chlorination and fluorination of quinols to offer the corresponding aromatic structures. Quinols,
or cyclohexadienones, as oxidized derivatives of phenols, have their remarkable chemical
reactivities, including additions to enone, enolate alkylations, aldol reactions, cycloadditions, and
rearrangements. Dienone-phenol rearrangement provides the asymmetric route since the
stereocenters located in the six-membered ring of various cyclohexadienone were widely using
in building larger chiral arrays for many total syntheses
Chapter one of this thesis discusses our new selective nucleophilic chlorination of quinol to
afford ortho- chloride phenol. This one-step selective chlorination can easily be performed using
readily available quinols and thionyl chloride. In Chapter two, inspired by chlorination strategy,
we develop a new fluorination strategy to offer fluorinated cyclohexadienone products by
deoxofluorination of quinols. Chapter three describes our study work on the total synthesis of
Strongylophorine-26.

The difficulties we met and our solution is discussed.
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Chapter 1 Selective Synthesis of ortho-Chlorophenol by Quinol
Nucleophilic Addition
1.1 Selective Synthesis of ortho-Chlorophenol by Quinol Nucleophilic Addition
1.1.1 Halogenation of Phenol
Halogenation of aryl compounds is a classic and prominent topic in organic chemistry. Organic
compounds containing halogen are an important and useful class of intermediates that can be
converted to other functionalities through simple chemical transformation. 1 The aryl halides, for
instance, can serve as starting materials for organometallic reagents and are frequently used as
precursors in pharmaceutical synthesis.2 Moreover, aryl halides and other halogen-containing
compounds are frequently used in metal-catalyzed organometallic coupling. A well-known
example is the Negishi Coupling, which allows the preparation of unsymmetrical biaryls by aryl
halide in good yields.3 Aryl halides also feature in the Hiyama coupling, which uses palladium
catalysts to form a new C-C bond,4 while the use of Grignard reagents with aryl halide in the
Kumada coupling enabled biaryl formation.5 Furthermore, aryl halides, along with aryl carboxylic
acid, aryl boronic acids, and aryl diazonium salts are considered as limited aryl radical sources.6
Due to the versatility of aryl halides, their synthesis is still viewed as a popular topic.
For aryl halide synthesis, phenol is often used as a precursor. Because phenols are highly
reactive to aromatic substitution, they are a good source of bulk complex compounds. However,
isomerism during the substitution reaction is hard to control.7 Halogenation of phenol usually
cannot stop in one substitution. Phenol with bromine water can directly form white precipitate
2,4,6-tribromophenol. In the past decade, hundreds of different methods have emerged to guide
selective halogenation of aromatic compounds and more than 70 phenol chlorination protocols.8
There are still two main challenges chemists face during halogenation of phenols: selectivity and

1

higher yields in mild conditions. NCS and H2SO4, first attempted in 1965, is the oldest selective
method for forming chlorination phenol, yet harsh conditions limit its wider use. Cl2 and silica
offered by Kiji is in mild condition and high yield, but some products are para-/ortho isomers
mixtures.10 Also, HCl can be used as a chlorinating reagent, and Bedekar reports HCl/H2O2
halogenation and the oxidation system can form chlorophenol.11 Under halogenation and
oxidation conditions, t-BuOCl are also used to produce chlorophenol.12 With all these methods
available, controlling selectivity is still an important challenge for every chemist.

1.1.2 Green Chemistry in the chlorination of phenols
During the last decade, environmental pollution in the synthesis kept drawing people’s attention,
green chemistry for halogenation already became the most popular research topic. The traditional
chlorination processes, which use many high toxic and biological hazard chlorination reagents and
produce many side products, are opposite to the principles of green chemistry. Basing on
principles of green chemistry, the design of new chlorination of phenols method asks less
hazardous reagent to achieve good selectivity and/or generate minimal waste or by‐products is our
new challenge.13
Chandalia’s oxidative halogenation strategy
Oxidative halogenation has found significant development in the preparation of organo-halogen
compounds. HCl/H2O2 system can benefit from low-cost resources and avoid the use of highly
toxic halogen reagents. However, HCl is difficult to oxidative with dilute H 2O2, and oxidative
chlorination is achieved by using an excess of HCl at higher temperatures. 14 Chandalia had
reported one sample of oxidative chlorination of 4-methylphenol to give 2-chloro-4-methyl
phenol, but this conversion faced problems like an excessive amount of acid using and low yield

2

(Scheme 1.1).15

Scheme

1.1

Selective

oxidative

monochlorination

to

synthesize

2-chloro-4-methyl phenol

Pd-catalyzed C–H chlorination in the selective synthesis of 2-chlorophenols16
Since classic approaches to the synthesis of 2-chlorophenols generally lack site-selectivity and
always

provide

a

mixture

of

o-

and

p-

isomers.17

Palladium-catalyzed

C-H

functionalization/halogenation has emerged as a particularly useful approach for producing
halogenated aromatic products with the selectivity that normally could not be obtained under
simple electrophilic halogenation conditions. Rao reported an example of a one spot synthesis of
valuable

2-chloro/bromophenols

through

a

room

temperature,

carbamate-directed,

palladium-catalyzed. Their method based on 1) under certain acidic condition, palladium catalysts
could promote C-H activation via an orthometalation process through weak coordination with the
carbonyl oxygen of phenol esters, carbonates or carbamates;18 2) a potential subsequent C-Cl bond
formation via the reductive elimination could afford the corresponding 2-chloro phenol derivatives
with suitable acids and chlorine-containing oxidants.19 After many attempts, they found under
room temperature Pd(OAc)2 catalyst with a small amount of TfOH phenol carbamates substrate
transformed into the corresponding 2-chloro phenol derivatives by NCS (Scheme 1.2).
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Scheme 1.2 Pd-catalyzed C–H chlorination in the selective synthesis of
2-chlorophenols

In summary, their mechanism could be i) chelate-directed C-H activation of the substrate
afforded a five-membered cyclopalladium ring ii) TfOH involved in the generation of Pd(OTf) 2
complex iii) Pd(II) was oxidized into a Pd(IV) intermediate iv) reductive elimination to afford
C-Cl bond products and Pd(IV) will be back to Pd(II) (Scheme 1.2).

4

Biosynthesis of chlorophenol
Natural chlorophenols were also found in some species. The blue-green alga Anacystis marina
contains 4-benzyl-2-chlorophenol. The acorn worm Ptychodera bahamensis produces two
halogenated phenols 3,4- dichloro- and 3,5-dichlorophenol.20 These biosynthesis paths may also
inspire scientists to improve our green chemistry synthesis method of chlorophenols.

1.1.3 Yin’s Nucleophilic Selective Chlorination of Quinone Monoketals
Quinols, as partly oxidized derivatives of phenols, exhibit different functional groups, such as
the hydroxy group, the double bond, and the carbonyl group. They have been widely used in the
synthesis of structurally complex molecules.21 One of the main reaction sites on quinols is the
tertiary alcohol moiety.22A well-known reaction involving this site is cyclohexadienone–phenol
rearrangement,15 which leads to either hydroquinone or resorcinol products24. Sorgi and colleagues
reported asymmetric desymmetrization of the double bonds in quinol derivatives via quinol and
diketene in the presence of a catalytic DMAP afforded a Cope [3,3]-sigmatropic rearrangement
product arylacetone (Scheme 1.3, a).25 In 2014, our group reported that quinone monoketals,
regiospecifically differentiated quinone equivalents, offered o-chlorophenols via an unexpected
nucleophilic chlorination mediated by N,N’-dimethylhydrazine dihydrochloride through a
regioselective 1,4-addition in situ formed more electron-withdrawing oxocarbenium (Scheme 1.3,
b).26 For a similar structure between quinol and quinone monoketal, we believe quinol could also
give chlorophenol between the hydroxyl group and electrophilic chlorination reagent by
intramolecular rearrangement or intermolecular addition. In order to develop a new protocol for
halogenation of aromatic compounds and extend the scope of reactivity of quinols in organic
synthesis, we have investigated thionyl chloride and sulfuryl chloride, two electrophilic
chlorination reagents, to prepare our reaction with 4-methyl quinol. We have observed that thionyl
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sulfuryl chloride offers a new product, while sulfuryl chloride does not offer any new product. This
product was proved to be 2-chloro-4-methylphenol by compared with the authentic compounds
2-chloro-4-methylphenol and 3-chloro-4-methylphenol (Fig. 1.1).

Scheme 1.3 Selective addition of quinol and quinone monoketal
a. Sorgi et al

b. 2014 our work

6

7

Fig. 1.1 1HNMR and 13CNMR for 2-chloro-4-methylphenol and 3-chloro-4-methylphenol.
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1.2 Selective Chlorination of Quinol to Form o-Chlorophenol with Thionyl Chloride in the
Presence of Base
1.2.1 Chlorination of Quinol by Thionyl Chloride
Scheme 1.4 Chlorination of quinol by thionyl chloride

Based on our findings, we initiated our investigation on 4-methyl quinol mixed with thionyl
chloride (Scheme 1.4). Using Et3N as base and dichloromethane as the solvent, at room
temperature, the reaction afforded the desired product 1.5a in just 22% yield (Table 1.1, entry 1).
The hydroxyl group on quinol performs as nucleophilic reagent approaching thionyl chloride, and
triethylamine accelerates this process by generating hydrogen chloride salt. This low yield is not
surprising since the chlorination process is an exothermic reaction, and parts of the reagents could
decompose. However, we optimized the temperature from room temperature (25 °C) to –46 °C.
The addition of thionyl chloride under ice bath (0 °C, followed by transferring the reaction to room
temperature (25 °C), was superior to the other conditions, which offered the highest yield, 64%,
and shortest reaction time, in one hour (entries 2 and 3). When performing the reaction under 0 °C,
we observed a lower yield (entry 4).
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Table 1.1 Temperature inferences to chlorination of 4-methyl quinol a
Entry

Reaction Condition

Time (h)

Yield (%) b

1

Room Temperature (25 °C)

1

22

2

Ice bath (0 °C)

4

64

3

Ice bath (0 °C) then room

1

62

4

56

temperature (25 °C) c
4

Acetonitrile Dry ice bath (-46 °C)

a. Reactions

was carried out in dichloromethane solution. b. Yield referring to isolated amount of product after
column chromatography. c. Reaction performed in ice bath (0 °C) for 20 mins.

With exception to dichloromethane, we also set up in other solvents to optimize solvent (Table
1.2). Both dichloromethane and 1,2-dichloroethane generate desired compound in the same yield
(entries 1 and 2). When dissolved in THF or dioxane, two ether aprotic solvents, the reaction gave
white precipitate instead of the chlorination product (entries 3 and 4). The addition of THF leads to
ClSO-THF complex and thus the coordination ability of THF to the reaction intermediates, which
could alter the reaction pathways, types, and population of the end products. 19 We predicted both
ethers would perform as nucleophilic reagent formed a precipitate with thionyl chloride. The use
of acetonitrile as a solvent resulted in no reaction, which thionyl chloride and acetonitrile may
generate complex (entry 5). Interestingly, the toluene mixture even provided the ortho-addition
product of about 30% yield (entry 6).
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Table 1.2 Optimization of reaction solvents a
Entry

Solution

Yield (%) b

1

Dichloromethane

62

2

1,2-Dichloroethane

61

3

THF

0

White precipitate in solution

4

1,4 dioxane

0

White precipitate in solution

5

Acetonitrile

6

Toluene

0

No change in solution

30

Solution turns to dark

a.

Reactions were carried out in ice bath (0 °C) for the first 20 mins. b. Yield referring to isolated amount of
product after column chromatography.

In the absence of base, chlorination can still occur, but the yield lowers to 11% (Table 1.3, entry
1). Variations of bases were investigated, and results indicated triethylamine, DBU and pyridine
were found to be equally efficient (Table 1.3, entries 2, 3, and 4). In fact, the addition of any base
showed an increase in reactivity towards chlorination.

Table 1.3 Optimization of bases

a. Yield

Entry

Base and chloride source

Yield (%) a

1

No base used

11

2

Et3N

62

3

DBU

62

4

Pyridine

61

referring to isolated amount of product after column chromatography.

In Table 1.4, TsCl, sulfuryl chloride, and acyl chloride were examined as chloride sources. All
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three showed no signs of chlorination (Table 1.4, entries 2, 3, and 4). We proposed that hydroxyl
quinols are weak nucleophiles that can only be activated with strong electrophiles such as thionyl
chloride. By introducing additional chloride sources of pyridine hydrochloride or
tetrabutylammonium chloride, we observed a decrease in the overall yield of desired product
ortho-chlorophenol to 40%~50% (Table 1.4, entries 5 and 6). These results support our theory that
selective chlorination happens through an intramolecular rearrangement path.

Table 1.4 Optimization of chlorination reagents a
Entry

Chlorination agent

Yield (%) b

1

Thionyl chloride

62

2

TsCl

0

3

Sulfuryl chloride

0

4

Acyl chloride

0

5

Pyridine hydrochloride c

47

6

TBACl d

43

a. Reactions

was carried out in dichloromethane solution. b. Yield referring to isolated amount of product after
column chromatography. c. Ratio of extra chloride source pyridine hydrochloride or TBACl to thionyl chloride
was 1:1. d. Tetrabutylammonium chloride.

With optimized conditions identified, we then explored the scope of quinol structures. All
quinols are prepared in one step from commercial phenols by PIDA oxidation according to
Tamura-Kita-Pelter protocol.28 The most promising results obtained from a screen of 18 quinols
are shown in Table 1.5. As for quinol thionyl chloride chlorination to afford the desired
o-chlorophenol products 1.5a-1.20a in high yields with moderate to high regioselectivities,
tolerating substituents such as cyclic, halogen, nitrile, carbonyl, and ester groups. Dimethyl and
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trimethyl substitutes quinols such as 2,4-dimethyl 1.6, 3,4-dimethyl 1.7, 3,4,5-trimethyl 1.8
quinols could offer good yield in 60% (Table 1.5, entries 2, 3, and 4). Notably, when 3,4-diemethyl
quinol 1.7 was employed as starting material, the desired products were obtained in two isomers
1.7a and 1.7b, in which the ratio between 1.7a and 1.7b is 22% to 44%, nearly 1 to 2 (entry 3). In
our opinion, steric effect of meta-methyl could block chloride to attack 2- position leads to 2addition chlorophenol was in lower yield, which was a good proof for quinol-thionyl chloride
complex should be through an intramolecular path to give chlorophenol; also, 6- position is more
electrophilic than 2- position that could increase difference in the ratio. Furthermore, ethyl, propyl,
isopropyl to cyclohexyl quinols 1.9-1.12 could offer particularly well chlorination products in
good yield around 60% (entries 5 to 8). Although the yield of chloro-cyclohexyl phenol is between
5% and 6% lower than others, it has been demonstrated that alkyl substitutes on 4- position could
not have the steric hindrance influence on the hydroxyl group which attackes the electrophilic
thionyl chloride and produces activated alcohol (entry 8).
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Table 1.5 Substrate scope of the selective chlorination of quinols

Entry

Quinol

1

1.5

Products

Yield (%) a
64

R1=Me, R2, R3, R4=H

2

1.6

63

R1, R3=Me, R2, R4=H

3

1.7

22

R1, R4=Me, R2, R3=H

44

4

1.8

56

R1, R2, R4=Me, R3=H

14

5

1.9

62

R1=Et, R2, R3, R4=H

6

1.10

64

R1=Pr, R2, R3, R4=H

7

1.11

65

R1=iPr, R2, R3, R4=H

8

1.12

55

R1=Hexyl, R2, R3,
R4=H

9

1.13

66

R1=Me,
R2, R3=CH2CH3CH2,
R4=H
10

1.14

22

R1, R2=CH2CH3CH2,
R3, R4=H

15

42

11

1.15

68

R1=Ph, R2, R3, R4=H

12

1.16

R1=

40

,

R2, R3, R4=H
13

1.17

R1=

31

,

R2, R3, R4=H

14

1.18

58

R1=CH2COCH3,
R2, R3, R4=H

16

15

1.19

60

R1=CH2COOCH3,
R2, R3, R4=H

16

73

1.20
R1=Me, R3=Br, R2,
R4=H

17

1.21

No product

R1=Me, R3=COOMe,
R2, R4=H
18

1.22

No product

R1=Me, R3=COMe, R2,
R4=H

a.

Yield referring to isolated amount of product after column chromatography.

Since cyclopentyl quinol 1.14a contains 2- and 6- two available positions, the reaction provided
two isomers 1.14a and 1.14b at 60% yield (entry 10). As can be seen from these two isomers,
unsurprisingly, the less steric hindrance chlorophenol 1.14b in higher yield 42% compared with
1.14a at 22% - a ratio of nearly 2 to 1. This regioselectivity of 1.14 agrees with the result of 1.7 and
can be attributed to intramolecular rearrangement. Cyclic 1.13 gave a 66% yield (entry 9).
In the case of electron-rich aromatic phenyl quinol and derivatives, using phenyl quinol 1.15 can
offer a 68% yield product 1.15a (entry 11). However, bromophenol 1.16 and benzonitrile 1.17,
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two quinols with electron-withdrawing substitutes, generated much lower yields than 1.15 (entries
12 and 13). In fact, the reason could be the electron-withdrawing group as cyano group would not
stabilize the intermediate structure. However, with both carbonyl structures 1.18 and 1.19, yields
do not dramatically decrease, which still have the desired product 1.18a, 1.19a at around 60%,
since these two electron-withdrawing groups not directly attach to aromatic ring (entries 14 and
15). Then the applicability of two strong electron-withdrawing groups with quinol 1.21, 1.22 were
also examined, but they could not offer any chlorinated product (entries 17 and 18). We proposed
that the intermediate resonance structure of ortho-carbonyl may transfer positive charge and block
further chlorination. Furthermore, 2-bromo quinol 1.20, the yield can still stable at 60% (entry 16).

1.2.2 Mechanism of Regioselective Chlorination
Table 1.6 Introducing extra or another halogen source
Entry

Halogen

Yield (%) a

1

Pyridine hydrochloride

47

2

TBACl

43

3

TBABr

No ortho-bromophenol

a.Yield

referring to isolated amount of product after column chromatography.

We proposed the selective chlorination of quinol starts from base-catalyzed condition
nucleophilic hydroxy group approaching thionyl chloride. Initially, we presented an
intramolecular path to form the o-chloride phenol by rearrangement. Otherwise, we could not deny
the possibility of an intermolecular path by anion chloride in solution (Scheme 1.3). Depending on
Sorgi condition, intramolecular rearrangement should be preferred. In the case of intramolecular
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rearrangement, if it is possible to have two desired products, the high-yield product will be one
with less steric hindrance. Otherwise, the intermolecular reaction will generate two isomers in the
same yield. As previously mentioned, 3,4-dimethyl quinol 1.7 offered two products 1.7a and 1.7b,
yield ratio was 1 to 2 (Table 1.5, entry 3); quinol 1.14 also generates two products 1.14a and 1.14b,
which 1.14b is twice as high as 1.14b (Table 1.5, entry 10). Notably, both 1.7b and 1.14b are less
steric hindrance products following intramolecular rearrangement. Moreover, in Table 1.6. after
we introduced pyridine hydrochloride and TBACl as extra chloride source, the yield decreased
(entries 1 and 2). With a new halogen source, TBABr, the new bromine anion should promote
ortho- bromide phenol in the intermolecular process (entry 3). However, we did not isolate the new
halogenation product. The regioselectivity of 1.7 and 1.14 agrees with the results obtained for the
reaction of extra chloride and bromide introduction and can be attributed to intramolecular
rearrangement in the transition state.
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Scheme 1.5 Possible mechanisms between quinol and thionyl chloride
Intramolecular

Intermolecular

1.2.3 Summary
In conclusion, we have demonstrated a new selective nucleophilic chlorination of quinol to
afford ortho- chloride phenol. This one-step selective chlorination can easily be performed using
readily available quinols and thionyl chloride. This conversion benefits from a simple procedure,
gentle conditions, and low-cost reagents without any expensive catalyst. At present, the reaction
has an acceptable yield of around 60%, however, the possible side products HCl and SO2 are
disadvantages to green chemistry principles. For our next step, we will try to improve the reaction
to have a higher yield and lower the pollution.
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Experimental Section
General Information
Anhydrous CH2Cl2 was distilled from CaH2 under an atmosphere of argon. All reagents were
purchased from commercial sources or synthesized using methods from the literature. 1H and 13C
NMR spectra were recorded on BRUKE 500 MHz spectrometers; 1H and

13C

NMR chemical

shifts (δ values) were reported in ppm from downfield using internal standard TMS (1H NMR) or
CDCl3(13C NMR), respectively. All mass spectra were run by the Hunter College Mass
Spectrometry Facility and taken on an Agilent 6520A Q-TOF using electrospray ionization. All
infrared spectra were taken on a Thermo Nicolet IR100 spectrometer. Column chromatography
was performed over silica with a porosity of 60 Å and a particle size of 40-63 µm. Coupling
constant (J) are reported in units of hertz (Hz). The following abbreviations are used to describe
multiplets: s (singlet), d (doublet), t (triplet), q (quartet), quint (quintuplet), sept (septet), m
(multiplet), br (broad).

Preparation of Quinol
Quinol are made from oxidation of phenols by phenyl iodo diacetate (PIDA) following general
procedures of and verified by 1H and 13C NMR.
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Chlorination of quinol with thionyl chloride

1.5

1.5a

1.5a: 2-chloro-4-methylphenol
Quinol 1.5 (1 mmol, 124 mg) was dissolved in DCM (3 ml) with triethylamine (1 mmol, 101 mg,
0.14 ml) at 0 °C. Thionyl chloride (1.2 mmol, 143 mg, 0.09 ml) was injected slowly. After 10
minutes of the addition of thionyl chloride, the reaction mixture was transferred under room
temperature (25 °C) and stirred for 2 hours. The reaction was then quenched with sodium
bicarbonate saturated solution (2 ml) and the solvent was extracted with DCM (3*2 ml). Then the
organic layer was washed with brine water (1 ml) and dried over Na2SO4. After filtration, then
extract was concentrated, and the residue was purified by chromatography (EtOAc/Hexane 1/10).
Product is yellow oil. Yield: 79 mg, 64%.
62% yield; 1H NMR (500 MHz, CDCl3) δ 7.12 (s, 1 H); 6.97 (d, J=2 Hz, 1 H); 6.88 (d, J=8 Hz, 1
H); 5.35, 13C NMR (500 MHz, CDCl3) δ 149.01, 130.98, 129.14, 128.97, 119.37, 115.77, 20.21.
MS m/z calculated for C7H7ClO [M+H+] 143.0, found 143.1.
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1.6a: 2-chloro-4,6-dimethylphenol
Quinol 1.6 (1 mmol, 138 mg) was dissolved in DCM (3 ml) with triethylamine (1 mmol, 101 mg,
0.14 ml) at 0 oC. Thionyl chloride (1.2 mmol, 143 mg, 0.09 ml) was injected slowly. After 10
minutes of the addition of thionyl chloride, the reaction mixture was transferred under room
temperature (25 °C) and stirred for 2 hours. The reaction was then quenched with sodium
bicarbonate saturated solution (2 ml) and the solvent was extracted with DCM (3*2 ml). Then the
organic layer was washed with brine water (1 ml) and dried over Na2SO4. After filtration, then
extract was concentrated, and the residue was purified by chromatography (EtOAc/Hexane 1/10).
The product is yellow oil. Yield: 87 mg, 63%.
64% yield; 1H NMR (500 MHz, CDCl3) δ 7.07 (s, 1 H); 6.95 (s, 1 H); 2.39 (s, 3 H); 2.28 (s, 3 H);
13C

NMR (500 MHz, CDCl3) δ 141.86; 137.29; 134.68; 130.63; 128.26; 126.38; 20.72; 17.58. MS

m/z calculated for C8H9ClO [M+H+] 157.0, found 157.0.
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1.7a

1.7b

1.7a: 2-chloro-3,4-dimethylphenol; 1.7b: 2-chloro-4,5-dimethylphenol
Quinol 9 (1 mmol, 138 mg) was dissolved in DCM (3 ml) with triethylamine (1 mmol, 101 mg,
0.14 ml) at 0 °C. Thionyl chloride (1.2 mmol, 143 mg, 0.09 ml) was injected slowly. After 10
minutes of the addition of thionyl chloride, the reaction mixture was transferred under room
temperature (25 °C) to room temperature and stirred for 2 hours. The reaction was then quenched
with sodium bicarbonate saturated solution (2 ml) and the solvent was extracted with DCM (3*2
ml). Then the organic layer was washed with brine water (1 ml) and dried over Na2SO4. After
filtration, then extract was concentrated, and the residue was purified by chromatography
(EtOAc/Hexane 1/10). The product is yellow oil. Yield: 1.7a, 30 mg, 22%; 1.7b, 60 mg, 44%. MS
m/z calculated for C8H9ClO [M+H+] 157.0, found 157.1.
1.7a: 22% yield; 1H NMR (500 MHz, CDCl3) δ 6.96 (d, J=10 Hz, 1 H); 6.79 (d, J=10 Hz, 1 H);
2.30 (s, 3 H); 2.29 (s, 3 H); 13C NMR (500 MHz, CDCl3) δ 148.95, 149.33, 134.66, 129.40, 128.63,
120.65, 116.29.
1.7b: 44% yield; 1H NMR (500 MHz, CDCl3) δ 7.05(s, 1 H); 6.80 (s, 1 H); 2.18 (s, 3 H); 2.15 (s, 3
H);

C NMR (500 MHz, CDCl3) δ 148.95, 137.04, 129.67, 129.67, 129.26, 117.16, 112.56,

13

19.50.18.74.
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1.8a: 2-chloro-3,4,5-trimethylphenol
Quinol 1.8 (1 mmol, 152 mg) was dissolved in DCM (3 ml) with triethylamine (1 mmol, 101 mg,
0.14 ml) at 0 °C. Thionyl chloride (1.2 mmol, 143 mg, 0.09 ml) was injected slowly. After 10
minutes of the addition of thionyl chloride, the reaction mixture was transferred under room
temperature (25 °C) and stirred for 2 hours. The reaction was then quenched with sodium
bicarbonate saturated solution (2 ml) and the solvent was extracted with DCM (3*2 ml). Then the
organic layer was washed with brine water (1 ml) and dried over Na2SO4. After filtration, then
extract was concentrated, and the residue was purified by chromatography (EtOAc/Hexane 1/10).
The product is yellow oil. Yield: 85 mg, 56%.
1.8a: 56% yield; 1H NMR (500 MHz, CDCl3) δ 6.72 (s, 1 H); 5.39 (s, 1 H); 2.33 (s, 3 H); 2.23 (s,
3 H); 2.14 (s, 3 H); 13C NMR (500 MHz, CDCl3) δ 148.56; 135.96; 134.18; 128.01; 123.05; 118.01;
114.50; 20.66; 17.16; 15.84. MS m/z calculated for C9H11ClO [M+H+] 171.0, found 171.0.
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1.9a: 2-chloro-4-ethylphenol
Quinol 1.9 (1 mmol, 138 mg) was dissolved in DCM (3 ml) with triethylamine (1 mmol, 101 mg,
0.14 ml) at 0 °C. Thionyl chloride (1.2 mmol, 143 mg, 0.09 ml) was injected slowly. After 10
minutes of the addition of thionyl chloride, the reaction mixture was transferred under room
temperature (25 °C) and stirred for 2 hours. The reaction was then quenched with sodium
bicarbonate saturated solution (2 ml) and the solvent was extracted with DCM (3*2 ml). Then the
organic layer was washed with brine water (1 ml) and dried over Na 2SO4. After filtration, then
extract was concentrated, and the residue was purified by chromatography (EtOAc/Hexane 1/10).
The product is yellow oil. Yield: 85 mg, 62%.
1.9a: 62% yield; 1H NMR (500 MHz, CDCl3) δ 7.14 (s, 1 H); 6.99 (d, J=5 Hz, 1 H); 6.91 (d, J=10
Hz, 1 H); 2.53 (q, J=5 Hz, 2 H); 1.18 (t, J=5 Hz, 2 H); 13C NMR (500 MHz, CDCl3) 149.14, 137.52,
128.02, 127.82, 27.80, 15.66. MS m/z calculated for C8H9ClO [M+H+] 157.0, found 157.0.
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1.10a: 2-chloro-4-propylphenol
Quinol 1.10 (1 mmol, 153 mg) was dissolved in DCM (3 ml) with triethylamine (1 mmol, 101 mg,
0.14 ml) at 0 °C. Thionyl chloride (1.2 mmol, 143 mg, 0.09 ml) was injected slowly. After 10
minutes of the addition of thionyl chloride, the reaction mixture was transferred under room
temperature (25 °C) and stirred for 2 hours. The reaction was then quenched with sodium
bicarbonate saturated solution (2 ml) and the solvent was extracted with DCM (3*2 ml). Then the
organic layer was washed with brine water (1 ml) and dried over Na2SO4. After filtration, then
extract was concentrated, and the residue was purified by chromatography (EtOAc/Hexane 1/10).
The product is yellow oil. Yield: 98 mg, 64%.
1.10a: 64% yield; 1H NMR (500 MHz, CDCl3) δ 7.12 (d, J=2 Hz, 1 H), 6.96 (dd, J=1.5 Hz, J=8 Hz,
1 H), 6.91 (d, J=8 Hz, 1 H), 2.47 (t, J=8 Hz, 2 H), 1.55 (m, J=7.5 Hz, 2 H), 0.90 (t, J=7.5 Hz, 3 H);
13C

NMR (500 MHz, CDCl3) δ 149.17, 135.96, 128.59, 128.40, 119.38, 115.85, 36.88, 24.57,

13.65. MS m/z calculated for C9H11ClO [M+H+] 171.0, found 1721.0.
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1.11a: 2-chloro-4-isopropylphenol
Quinol 1.11 (1 mmol, 153 mg) was dissolved in DCM (3 ml) with triethylamine (1 mmol, 101 mg,
0.14 ml) at 0 °C. Thionyl chloride (1.2 mmol, 143 mg, 0.09 ml) was injected slowly. After 10
minutes of the addition of thionyl chloride, the reaction mixture was transferred under room
temperature (25 °C) and stirred for 2 hours. The reaction was then quenched with sodium
bicarbonate saturated solution (2 ml) and the solvent was extracted with DCM (3*2 ml). Then the
organic layer was washed with brine water (1 ml) and dried over Na2SO4. After filtration, then
extract was concentrated, and the residue was purified by chromatography (EtOAc/Hexane 1/10).
The product is yellow oil. Yield: 100 mg, 65%.
1.11a: 65% yield; 1H NMR (500 MHz, CDCl3) δ 6.69 (d, J=3.5 Hz, 1 H), 6.63 (d, J=10 Hz, 1 H),
6.54(dd, J=3.5 Hz, J=10 Hz, 1 H), 3.19 (m, J=9 Hz, 1 H), 1.23 (d, J=8.5 Hz, 6 H); 13C NMR(500
MHz, CDCl3) δ 149.59, 146.63, 135.92, 116.06, 113.39, 112.89, 29.70, 27.11, 22.50. MS m/z
calculated for C9H11ClO [M+H+] 171.0, found 171.0.
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1.12a: 2-chloro-4-cyclohexylphenol
Quinol 1.12 (1 mmol, 192 mg) was dissolved in DCM (3 ml) with triethylamine (1 mmol, 101 mg,
0.14 ml) at 0 °C. Thionyl chloride (1.2 mmol, 143 mg, 0.09 ml) was injected slowly. After 10
minutes of the addition of thionyl chloride, the reaction mixture was transferred under room
temperature (25 °C) and stirred for 2 hours. The reaction was then quenched with sodium
bicarbonate saturated solution (2 ml) and the solvent was extracted with DCM (3*2 ml). Then the
organic layer was washed with brine water (1 ml) and dried over Na2SO4. After filtration, then
extract was concentrated, and the residue was purified by chromatography (EtOAc/Hexane 1/10).
The product is yellow oil. Yield: 106 mg, 55%.
55% yield; 1H NMR (500 MHz, CDCl3) δ 7.14 (d, J=2 Hz, 1 H), 6.99 (dd, J=2 Hz, J=8 Hz, 1 H),
6.91 (d, J=8.5 Hz, 1 H), 5.44 (s, 1 H), 2.38 (m, J=3 Hz, J=8 Hz, 1 H), 1.81 (t, J=9 Hz, 4 H), 1.71 (d,
J=15 Hz, 1 H), 1.33 (m, J=6 Hz, 4 H), 1.28 (m, J=3.5 Hz, 1 H); 13C NMR (500 MHz, CDCl3) δ
149.18, 141.54, 127.02, 126.79, 43.52, 34.54, 26.78, 26.02. MS m/z calculated for C12H15ClO
[M+H+] 211.1, found 211.1.
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1.13a: 5-chloro-7-methyl-2,3-dihydro-1H-inden-4-ol
Quinol 1.13 (1 mmol, 164 mg) was dissolved in DCM (3 ml) with triethylamine (1 mmol, 101 mg,
0.14 ml) at 0 °C. Thionyl chloride (1.2 mmol, 143 mg, 0.09 ml) was injected slowly. After 10
minutes of the addition of thionyl chloride, the reaction mixture was transferred under room
temperature (25 °C) and stirred for 2 hours. The reaction was then quenched with sodium
bicarbonate saturated solution (2 ml) and the solvent was extracted with DCM (3*2 ml). Then the
organic layer was washed with brine water (1 ml) and dried over Na2SO4. After filtration, then
extract was concentrated, and the residue was purified by chromatography (EtOAc/Hexane 1/10).
The product is yellow oil. Yield: 108 mg, 66%.
1.13a: 66% yield; 1H NMR (500 MHz, CDCl3) δ 6.91 (s, 1 H), 5.33 (s, 1 H), 2.91 (t, J=7.5 Hz, 2 H),
2.78 (t, J=7.5 Hz, 2 H), 2.22 (s, 3 H), 2.12 (m, J=1.0 Hz, 2 H); 13C NMR (500 MHz, CDCl3) δ
145.38, 144.12, 130.43, 126.38, 116.69, 31.67, 30.96, 29.84, 18.30. MS m/z calculated for
C10H11ClO [M+H+] 183.1, found 183.1.
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1.14a

1.14b

1.14a: 4-chloro-2,3-dihydro-1H-inden-5-ol;
1.14b: 6-chloro-2,3-dihydro-1H-inden-5-ol.
Quinol 1.14 (1 mmol, 150 mg) was dissolved in DCM (3 ml) with triethylamine (1 mmol, 101 mg,
0.14 ml) at 0oC. Thionyl chloride (1.2 mmol, 143 mg, 0.09 ml) was injected slowly. After 10
minutes of the addition of thionyl chloride, the reaction mixture was transferred under room
temperature (25 °C) and stirred for 2 hours. The reaction was then quenched with sodium
bicarbonate saturated solution (2 ml) and the solvent was extracted with DCM (3*2 ml). Then the
organic layer was washed with brine water (1 ml) and dried over Na 2SO4. After filtration, then
extract was concentrated, and the residue was purified by chromatography (EtOAc/Hexane 1/10).
The product is yellow oil. Yield: 1.14a, 33 mg, 22%; 1.14b, 63 mg, 42%.
1.14a: 22% yield; 1H NMR (500 MHz, CDCl3) δ 6.92 (d, J=10 Hz, 1 H), 6.73 (d, J=8 Hz, 1 H),
5.32 (s, 1 H), 2.86 (m, J=8 Hz, 4 H), 2.05(m, J=7.5 Hz, 2 H);

13C

NMR (500 MHz, CDCl3) δ

149.68, 141.52, 137.29, 123.21, 111.94, 33.09, 32.59, 25.90.
1.14b: 42% yield; 1H NMR (500 MHz, CDCl3) δ 7.05 (s, 1 H), 6.79 (s, 1 H), 5.34 (s, 1 H), 2.76 (m,
J=7.5 Hz, 4 H), 1.97 (m, J=7.5 Hz, 2 H); 13C NMR (500 MHz, CDCl3) δ 149.54, 144.92, 137.14,
124.17, 118.59, 113.90, 32.81, 32.11, 25.21. MS m/z calculated for C9H9ClO [M+H+] 179.0, found
169.0.
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1.15a: 3-chlorobiphenyl-4-ol
Quinol 1.15 (1 mmol, 186 mg) was dissolved in DCM (3 ml) with triethylamine (1 mmol, 101 mg,
0.14 ml) at 0 °C. Thionyl chloride (1.2 mmol, 143 mg, 0.09 ml) was injected slowly. After 10
minutes of the addition of thionyl chloride, the reaction mixture was transferred under room
temperature (25 °C) and stirred for 2 hours. The reaction was then quenched with sodium
bicarbonate saturated solution (2 ml) and the solvent was extracted with DCM (3*2 ml). Then the
organic layer was washed with brine water (1 ml) and dried over Na 2SO4. After filtration, then
extract was concentrated, and the residue was purified by chromatography (EtOAc/Hexane 1/10).
The product is yellow oil. Yield: 126 mg, 68%.
1.15a: 68% yield; 1H NMR (500 MHz, CDCl3) δ 7.55 (d, J=2 Hz, 1 H), 7.52 (d, J=1 Hz, J=2 H),
7.41 (t, J=7.5 Hz, 3 H), 7.31 (t, J=7.5 Hz, 1 H), 5.55 (s, 1 H);

13C

NMR (500 MHz, CDCl3) δ

150.73, 139.56, 134.98, 128.85, 128.72, 127.48, 127.14,126.71, 120.24, 116.48, 115.63. MS m/z
calculated for C12H9ClO [M+H+] 205.0, found 205.0.
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1.16a: 4'-bromo-3-chlorobiphenyl-4-ol
Quinol 1.16 (1 mmol, 264 mg) was dissolved in DCM (3 ml) with triethylamine (1 mmol, 101 mg,
0.14 ml) at 0 °C. Thionyl chloride (1.2 mmol, 143 mg, 0.09 ml) was injected slowly. After 10
minutes of the addition of thionyl chloride, the reaction mixture was transferred under room
temperature (25 °C) and stirred for 2 hours. The reaction was then quenched with sodium
bicarbonate saturated solution (2 ml) and the solvent was extracted with DCM (3*2 ml). Then the
organic layer was washed with brine water (1 ml) and dried over Na 2SO4. After filtration, then
extract was concentrated, and the residue was purified by chromatography (EtOAc/Hexane 1/10).
The product is yellow oil. Yield: 106 mg, 40%.
1.16a: 40% yield; 1H NMR (500 MHz, CDCl3) δ 7.55 (m, J=7 Hz, 3 H), 7.38 (d, J=8.5 Hz, 3 H),
7.09 (d, J=8.5 Hz, 1 H); 13C NMR (500 MHz, CDCl3) δ 151.03, 138.46, 133.62, 131.97, 128.30,
128.28, 127.34, 126.98, 121.52, 116.57. MS m/z calculated for C12H8ClBrO [M+H+] 283.0, found
283.0.
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1.17a: 3'-chloro-4'-hydroxybiphenyl-4-carbonitrile
Quinol 1.17 (1 mmol, 211 mg) was dissolved in DCM (3 ml) with triethylamine (1 mmol, 101 mg,
0.14 ml) at 0 °C. Thionyl chloride (1.2 mmol, 143 mg, 0.09 ml) was injected slowly. After 10
minutes of the addition of thionyl chloride, the reaction mixture was transferred under room
temperature (25 °C) and stirred for 2 hours. The reaction was then quenched with sodium
bicarbonate saturated solution (2 ml) and the solvent was extracted with DCM (3*2 ml). Then the
organic layer was washed with brine water (1 ml) and dried over Na 2SO4. After filtration, then
extract was concentrated, and the residue was purified by chromatography (EtOAc/Hexane 1/10).
The product is yellow oil. Yield: 65 mg, 31%.
1.17a: 31% yield; 1H NMR (500 MHz, CDCl3) δ 7.65 (d, J=8.5 Hz, 2 H), 7.55(d, J=8 Hz, 2 H),
7.51(d, J=1.5 Hz, 1 H), 7.37(dd, J=1.5 Hz, J=8.5 Hz, 1 H), 7.07(d, J=8.5 Hz, 1 H); 13C NMR (500
MHz, CDCl3) δ 151.88, 143.92, 132.73, 127.73, 127.34, 127.23, 118.87, 116.91, 115.30, 110.84.
MS m/z calculated for C13H9ClNO [M+H+] 230.0, found 230.0.
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1.18a: 1-(3-chloro-4-hydroxyphenyl) propan-2-one
Quinol 1.18 (1 mmol, 166 mg) was dissolved in DCM (3 ml) with triethylamine (1 mmol, 101 mg,
0.14 ml) at 0 °C. Thionyl chloride (1.2 mmol, 143 mg, 0.09 ml) was injected slowly. After 10
minutes of the addition of thionyl chloride, the reaction mixture was transferred under room
temperature (25 °C) and stirred for 2 hours. The reaction was then quenched with sodium
bicarbonate saturated solution (2 ml) and the solvent was extracted with DCM (3*2 ml). Then the
organic layer was washed with brine water (1 ml) and dried over Na 2SO4. After filtration, then
extract was concentrated, and the residue was purified by chromatography (EtOAc/Hexane 1/10).
The product is yellow oil. Yield: 96 mg, 58%.
58% yield; 1H NMR (500 MHz, CDCl3) δ 7.26 (s, 1 H); 6.99 (d, J=8.5 Hz, 1 H); 6.96 (d, J=8.5 Hz,
1 H); 5.67 (s, 1 H); 3.62 (s, 1 H); 2.17(s, 3 H); 13C NMR (500 MHz, CDCl3) δ 206.25; 150.49;
129.79; 129.45; 127.20; 120.00; 116.44; 49.54; 29.36. MS m/z calculated for C9H9ClO2 [M+H+]
185.0, found 185.1.
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1.19a: ethyl 2-(3-chloro-4-hydroxyphenyl) acetate
Quinol 1.19 (1 mmol, 182 mg) was dissolved in DCM (3 ml) with triethylamine (1 mmol, 101 mg,
0.14 ml) at 0 °C. Thionyl chloride (1.2 mmol, 143 mg, 0.09 ml) was injected slowly. After 10
minutes of the addition of thionyl chloride, the reaction mixture was transferred under room
temperature (25 °C) and stirred for 2 hours. The reaction was then quenched with sodium
bicarbonate saturated solution (2 ml) and the solvent was extracted with DCM (3*2 ml). Then the
organic layer was washed with brine water (1 ml) and dried over Na 2SO4. After filtration, then
extract was concentrated, and the residue was purified by chromatography (EtOAc/Hexane 1/10).
The product is yellow oil. Yield: 109 mg, 60%.
60% yield; 1H NMR (500 MHz, CDCl3) δ 7.24 (d, J=1.5 Hz, 1 H), 7.05 (dd, J=8.5 Hz, J=2 Hz，1
H), 6.92 (d, J=8 Hz, 1 H), 5.80 (s, 1 H), 3.70 (s, 3 H), 3.53 (s, 2 H); 13C NMR (500 MHz, CDCl3)
δ 172.09, 150.59, 129.77, 129.30, 126.91, 119.89, 116.33, 52.26, 39.93. MS m/z calculated for
C9H9ClO3 [M+H+] 201.0, found 201.1.
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1.20a: 2-bromo-6-chloro-4-methylphenol
Quinol 1.20 (1 mmol, 203 mg) was dissolved in DCM (3 ml) with triethylamine (1 mmol, 101 mg,
0.14 ml) at 0 °C. Thionyl chloride (1.2 mmol, 143 mg, 0.09 ml) was injected slowly. After 10
minutes of the addition of thionyl chloride, the reaction mixture was transferred under room
temperature (25 °C) and stirred for 2 hours. The reaction was then quenched with sodium
bicarbonate saturated solution (2 ml) and the solvent was extracted with DCM (3*2 ml). Then the
organic layer was washed with brine water (1 ml) and dried over Na2SO4. After filtration, the
extract was concentrated, and the residue was purified by chromatography (EtOAc/Hexane 1/10).
The product is yellow oil. Yield:148 mg, 73%.
1H

NMR (500 MHz, CDCl3) δ 7.12 (s, 1 H), 7.00 (s, 1 H), 5.55 (s, 1 H), 3.31 (s, 3 H); 13C NMR

(500 MHz, CDCl3) δ 145.22, 134.56, 132. 18, 129.21, 126.35, 21.11. MS m/z calculated for
C7H6ClBrO [M+H+] 221.0, found 221.0.

40

41

42

43

44

45

46

47

48

49

50

51

52

53

54

55

56

57

58

59

60

61

62

63

64

65

66

67

68

Chapter 2 Deoxofluorination between Diethylaminousulfur
Trifluoride (DAST) and Quinol
2.1 Fluorine Chemistry from Past to Now on
2.1.1 Fluorine Chemistry from 19th Century to Modern Time 1, 2
Fluorine, its element name came from ‘fluor’ in mineral fluorspar which today called calcium
fluoride. The ‘fluor’ in the Latin word ‘fluere’ means ‘to flow’ since it was added to metal ores to
lower their melting points for smelting. However, many talented chemists were killed by this fatal
element on the isolating process, even those injured, and death called ‘fluorine martyrs.’ Those
early pioneers such as Davy, Gay-Lussac, and Thenard all suffered intensely from the effects of
inhaling small quantities of hydrogen fluoride vapor; Davy’s eyes also were damaged by the gas.1
Two members of the Royal Irish Academy, George Knox and his brother, the Reverend Thomas
Knox, were unable to liberate the halogen from fluorspar, and both suffered the frightful torture of
hydrofluoric acid poisoning.3 The Reverend Thomas Knox nearly lost his life, and George Knox
had to rest in Naples for three years to regain his health. P. Louyet of Brussels, under full
knowledge of the Knox brothers’ misfortune, continued his dangerous researches and devoted his
life to science4-6. Professor Jerome Nickles of Nancy met a similar fate.7-9 French chemist Henri
Moissan, continued the search of isolating fluorine after his mentor Edmond Frémy. After many
unsuccessful attempts to electrolyze fluoride and poisoned by side products, Moissan finally used
electrolyte, which was a solution of dry potassium acid fluoride in anhydrous hydrofluoric acid.
On June 26, 1886, a gas appeared at the anode, and when he tested it with silicon, it immediately
burst into flame. The burning product was proved as silicon fluoride and the small gas bubble was
pure fluorine. This is the first-time chemist isolated fluorine element and Henri Moissan received
the 1906 Nobel Prize in Chemistry for his achievement.
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Belgian chemist, Frédéric Swarts, a professor in the civil engineer at the University of Ghent,
started his studies on the preparation of fluorocarbon compounds around 1890. From 1900 he was
virtually the only worker publishing in the field.11 During his work until to 1938, he contributed a
great deal in outlining methods of preparation for many partly fluorinated compounds. Swarts
made trifluoroacetic acid as early as 1922 and in 1931 reported synthesis of pure perfluoroethane
by electrolysis of an aqueous solution.12-13 Midgley and Henne were able to apply fluoromethanes
and ethanes as refrigerants by basing on Swarts’ work in 1930. 14 Lebeau and Damiens reported
tetrafluoromethane in 1926 which was the first pure isolated perfluorocarbon. 15 The first liquid
perfluorocarbon was introduced in 1937 when Simons and Block found that mercury promotes
reaction between carbon and fluorine which were able to isolate CF4, C2F6, C3F8, C4F10 (two
isomers), cyclo-C6F12 and C6F14.16 Tetrafluoroethene was obtained by Ruff and Bretschneider in
1933, who decomposed tetrafluoromethane in an electric arc while Locke developed a synthesis
in 1934, which involved zinc dehalogenation of CF2Cl2CF2Cl.17-18 Early fluoropolymer,
polytetrafluoroethylene was discovered in 1938 and then polymerized chlorotrifluoroethylene
which was proved as a very stable inert transparent polymer.19 In the Second World War period,
the war involved the development of fluoropolymer and other new materials, and the potential of
fluorinated compounds was recognized by chemists. So, after the war, organofluorine progress has
been extremely rapid. In the 1950s, many fluoride functional derivatives were synthesized, and a
new area fluorocarbon organometallic chemistry was in chemists’ eyes. Non-flammable fluorinecontaining inhalation anesthetics was introduced as the synthesis of the earliest fluorinated drugs.
Fluorinated elastomers are critical materials in the development of supersonic and space light.
Then from the 1960s to now on, perfluoro aromatic chemistry was rapidly developed, selective
methods for fluorination were introduced, and more and more fluorinated compounds play an
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increasingly important role in the pharmaceutical and plant-protection.20 In the early 1990s, 6.2%
compounds registered in Chemical Abstracts (CA) own C-F bound. Industry sources estimate that
as many as 30-40% of agrochemicals and 20% of pharmaceuticals on the market contain fluorine.21
Also fluorine is used to tag biochemical probes for the study of various biological processes, as
the NMR activity of the 19F nuclei enables in vivo magnetic resonance imaging.21 In addition, 18Fpositron-emitting tomography is used daily for diagnosing, staging, and detecting the recurrence
or progression of various diseases including cancer.22 Organofluorine chemistry is an outstanding
output for the relatively limited number of workers in the field worldwide and is a tribute to their
dedication.23

2.1.2 Typical Organofluorine Compounds
Natural Organofluorine Product
Even the fluorine is the 13th richest element on Earth’s crust (Chlorine ranks 20th) and the most
common halogen, natural products with fluorine are still the rarest and only about a dozen
fluorinated natural products have been isolated.24 This confusing puzzle can be explained as 1)
fluorspar (CaF2) and cryolite (Na3AlF6) contain most fluorine as minerals, which hardly delivery
to aqueous biological systems; 2) the highest oxidation potential of fluorine obstructs through
enzymatic halogenation pathway to form intermediate hypohalous species by vanadium dependent
halogenases and H2O2; 3) fluorine is a poor nucleophile under aqueous biological conditions by
its extraordinary high hydration energy which the general nucleophilic opening of epoxide
intermediates with halide anions by enzymatic incorporation is blocked; 4) the last pathway for
biological halogenation involves a radical mechanism, however fluorine’s radical is difficult to
generate and its violent reactivity would prevent any regio/chemoselectivity. 25 The first fluorinase
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enzyme has been discovered that catalyzes carbon-fluorine bond formation in 200226 from
bacterium Streptomyces cattleya and until 2007 other 9 structures of this class of enzyme were
isolated (Fig 2.1).

Fig 2.1 The fluorinase enzyme from Streptomyces cattleya mediates the conversion of S-adenosylL-methionine (SAM) to 5’-fluoro-5’-deoxyadenosine (5’-FDA)
The first natural fluorine product was found in 1943, fluoroacetate, which is a metabolite of the
Southern African plant Dichapetalum cymosum.27 Monofluoroacetate also can produce by tropical
and subtropical plants Palicourea marcgravii, Acacia georginae, Gastrolobium grandiflorum, and
Oxylobium species.28 Plants with monofluoroacetate are toxic and have negatively affected
livestock production in the worldwide area throughout recorded history. They caused livestock
sudden death and heavy losses in South Africa, Australia and other areas in the world.
Nevertheless, people also employed sodium monofluoroacetate as a pesticide on the control of
mammalian pests such as rodents, introduced foxes, feral dogs and cats, introduced possums, and
native predators such as coyotes.29 Other natural organofluorine compounds, 4-fluorothreonine is
fluorine contained amino acids as a co-product of monofluoroacetate in bio-synthesis.30
Fluorocitrate is also found in some of the toxic plants but in low concentration. ω-Fluorooleic acid
was isolated from Datura toxicarium also as a toxin. Nucleocidin has been considered as an
antibiotic, but it has proven difficult to explore the biosynthesis of this metabolite as the strains
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deposited in public collections do not have the capacity to biosynthesize the antibiotic, so the
nature of fluorine incorporation into nucleocidin is unresolved.31

Fig 2.2 Natural fluorine products
Organofluorine Pharmaceuticals
Organofluorine compounds attract more and more attention from global scientists for their
important pharmaceutical performing. By estimating nearly 20% of pharmaceuticals prescribed or
administered in the clinic contain a fluorine atom and 30% of leading 30 blockbuster drugs by
sales contain a fluorine.32 Effect of fluorine can strongly modify physicochemical properties in
lipophilicity, conformation, hydrogen bonding, electrostatic interactions and pharmacokinetic
properties in metabolic stability.33

Fig 2.3 Fluoxetine, commercial brand name Prozac
Fluoxetine, the commercial brand name Prozac, is a well-known antidepressant drug, featuring
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a trifluoromethyl group on one of its aryl rings. It was synthesized by Eli Lilly in 1974 and
approved by the Food and Drug Administration (FDA) in 1987. The annual sales in the U.S.
reached $350 million within a year and world worldwide sales reached $2.6 billion a year at a
peak. Fluoxetine acts by selectively inhibiting the reuptake of serotonin of which low level can
lead depressants. It is believed that the steric bulk of the trifluoromethyl group at this position
allows the phenoxy ring to adopt a conformation which favors binding to the serotonin transporter,
especially the potency for inhibiting of trifluoromethyl group in the para- position is much higher
than non-fluorinated parent compound.34

Fig 2.4 5-Fluorouracil and Capecitabine

5-fluorouracil is one of those earliest synthetic fluorinated drugs which was finished in 1957 as
antimetabolite used in chemotherapy for cancer.35 This drug has two primary mechanisms of action
capable of inducing cytotoxicity. First, 5-fluorouracil is phosphorylated to fluorouridine
triphosphate, a fraudulent nucleotide, which is incorporated into RNA by RNA polymerase,
inhibiting RNA synthesis and function. Second, it inhibits thymidylate synthetase, depleting
intracellular levels of thymidine monophosphate and thymidine triphosphate which are essential
for DNA synthesis.36 However. The 5-fluorouracil has strong toxicity to lead side effects, diarrhea,
nausea, sores, poor appetite, and other uncomfortable conditions to more than 30% of patients.
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Therefore, using strategies to reduce such side effects has been highly pursued. In this case, a new
medicine Capecitabine was synthesized and launched by Roche. In 2011, Capecitabine was
reported producing a $1.532 billion sales amount.37

Fig 2.5 Atorvastatin (Lipitor)
Lipitor (atorvastatin calcium) was the first drug to reach the annual sales of 10 billion dollars and
currently is one of the top-selling pharmaceutical products in the world.38 It belongs to the statin
medication family, which is HMG-CoA reductase inhibitor. Atorvastatin, was proved to lower the
risk for heart attack, stroke, certain types of heart surgery since it can reduce LDL-C level and
increase HDL-C level.39 According to reports, Lipitor in moderate- to high-risk patients were
achieved at a relatively low incremental cost and, across the economic analyses, a substantial
proportion of atorvastatin acquisition costs was offset by reductions in healthcare resource use
associated with cardiovascular events.40

2.1.3 Interaction of C-F Bonds41
Since fluorine is highly electronegative and fluoronium species F+ has never been observed, the
C-F bond is highly polarized, less covalent and more electrostatic. The C-H bond and C-F bond
will be different in (a) electronegativity differences, (b) the existence of unshared electron pairs
associated with fluorine, (c) the tendency for displacement of fluorine as F from unsaturated
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fluorocarbons, (d) the higher bond strength of C-F than C-H and, to a lesser extent, (e) the larger
size of fluorine than hydrogen.42 Then we also can expect the C-F bond to other halogen carbon
bond especially the C-Cl bond have difference in (a) the larger steric requirements, (b) the lower
bond strength of C-Cl than C-F, and (c) the greater availability of 3d orbitals of chlorine.43
C-F bond is the strongest bond in organic chemistry since bond dissociation energy is much
higher than C-H, C-O, and C-Cl. Fluorine has the greatest propensity to attract electron density
and electron density particular on fluorine, so the electrostatic attraction between Cδ+ and Fδcontributes more bond strength than classical electron sharing of a covalent bond in C-F bond.
This polarization of the C-F bond leads to geometric changes in hydrocarbons.44 The fluorine pulls
valence electron density towards it and this relaxes the electron repulsion between the electronrich C-H bonds, so they spread out a little. In CH3F, the H-C-H angle widens but the H-C-F angle
shrinks, comparing with CH4.45 On the opposite, the strongest polarity of the C-F bond does not
make fluorine become the best leaving group. Fluorine ion is the poorest leaving group even carbon
with a strong positive charge on itself should attract nucleophiles very well. Electrostatic stabilizes
the C-F bond and resists polarization toward free fluoride ions. Then the electrostatic also gives a
large dipole moment in the C-F bond, if when compounds with other substitutes offering dipole
moment, the molecular conformations are rearranged by dipole-dipole interactions, which some
steric structures will be favored.
Considering the polarity of the C-F bond and three lone pairs on fluorine, fluorine should act as
a good hydrogen bond acceptor. However, organic fluorine compounds only form weak hydrogen
bonds. First, because great electronegativity and low polarizability of fluorine which holds its lone
pairs, suppresses its electrostatic influence and renders it a poor hydrogen bond acceptor. 46 Second,
the C-H bond is also a weak hydrogen bond donor. Thus, fluorine also cannot act as π-donor, or
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only contributes lone pairs for conjugation in the most extreme case of a full positive charge. 47

Fig.2.6 The fluorine long hydrocarbon chain performs a helical arrangement of the C-F bonds but
not an anti-zigzag structure in all-syn multivicinal fluorinated chain.
The C-F bond’s hyperconjugation effect for a highly polarized aspect of the C-F bond is the
presence of a low lying σ* C-F antibonding orbital. In 1,2-difluoroethane, two fluorine atoms
prefer a gauche rather than an anti-conformation which is opposite to other 1.2-dihalogen
compounds, because the gauche conformer supports hyperconjugation model σC-H…σ*C-F
interactions. Then in 1,3-fluorine bond, the two fluorine atoms repel each other to form σCH…σ*C-F interactions. Combinations of the 1,2-gauche effect and 1,3-dipolar repulsion reveal
themselves in the lowest energy conformations of all-syn multivicinal fluorinated chains.48 The
fluorine long hydrocarbon chain performs a helical arrangement of the C-F bonds but not an antizigzag structure.
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2.2 Fluorination of Quinol
2.2.1 Synthesis of Complex Organofluorine Compounds
At an early age, the organofluorine compounds based on the synthesis of small molecular
compounds through gas F2, HF and metal fluorides. However, they are expensive and high toxins.
The general strategies of synthesis of the C-F bond can be nucleophilic, electrophilic, and radical.
The nucleophilic fluorination is probably the most important route to fluorinated fine chemicals in
all three paths. The fluoride ion acts as the nucleophile while in reaction. Traditionally, alkali metal
fluorides like KF, CsF are used as fluorine sources but their low solubility in organic solvent
influences the effectiveness of the method. HF-based reagents HF/pyridine, Et3N·3HF are
employed to introduce fluorine to other substrates. Hypervalent halogen derivatives were
developed in the 1980s, by Tsushima and co-workers with para-iodotoluene difluoride for a
fluorination reaction.1 The tetraalkylammonium fluorides are widely used fluorine agent, as TBAF
and sources related to TBAF.2-3 In electrophilic fluorination, the nucleophilic substrates choose
from carbanion, an electron-rich unsaturated double bond, or a substrate bearing a nucleophilic
and labile bond. However, the electrophile is a reagent that delivers an equivalent of “F +”,
traditionally with O-F bond, Xe-F bond or F-F bond. These reagents face problems like high
reactivity, low selectivity, and absence of commercial sources. In the past years, scientists
improved the electrophilic strategy with N-F reagent, for example, 1-chloromethyl-4-fluoro-1,4diazoniabicyclo [2.2.2] octane bis(tetrafluoroborate), which is one of the best reagents used as an
electrophilic fluorine donor. Radical fluorination also faces problems which most reagents are
expensive noble gas reagent or high hazardous reagents, since a carbon-based radical and atomic
fluorine sources which mostly has been restricted to molecular F2, hypofluorites, and XeF2
(radical).
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2.2.2 Fluorination of Quinol.
Quinols as an oxidation product of phenol in a water solution containing functional groups
ketone, hydroxy and diene, perform a very special chemical activity in the synthesis of complex
compounds. In 2013, we published the synthesis of bicyclic oxazolidinones from quinols and
isocyanates.4 And we also continue to develop a new one-spot synthesis of acridones from quinols.
Recently, approaching o-chlorophenol by quinol and thionyl chloride in mild condition with
activated hydroxyl group performing nucleophile addition was developed by us (Chapter one). The
findings from these studies suggest that quinol can offer complex building blocks with a
nucleophilic reagent. Therefore, even if fluoride acting as a weak nucleophile, it also can be
expected that activated hydroxyl group with fluoride nucleophile reagent can also achieve
fluorophenol. Karam and co-workers found the ipso-fluorination of para-substituted phenols in
PIDA or PIFA oxidation process with Olah reagent (pyridinium polyhydrogen fluoride).5
However, their study did not consider the wide range and complex structures and another weakness
was that Olah reagent is highly toxic and unstable.

Fig 2.7 Karam’s oxidative ipso-fluorination of para-substituted phenols using pyridinium
polyhydrogen fluoride in combination with hypervalent iodine (III) reagents.

Various strategies have been considered for the synthesis of new fluorination quinol. As
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nucleophilic

fluorination,

the

widely

choosing

reagents

concluding

metal

fluoride,

trifluormehansulfonic, TBAF (tetra-n-butylammonium fluoride), hydrogen fluoride pyridine and
DAST has been envisioned. Trifluoromethanesulfonic anhydride, methanesulfonic anhydride, and
diphenyl phosphoryl chloride all can be reagent to activate hydroxyl group. However, fluoride is
not as good as chloride in ortho addition since fluoride was a weak nucleophile in the protic
environment. We failed to obtain the desired product by alkali metal fluoride KF, CsF and
transition metal fluoride AgF. Considering metal fluoride fluorination mostly focuses on Pd (0)
cross-coupling, metal fluoride may not be a good fluorine source in deoxofluorination. 6
Trifluoromethanesulfonic anhydride and methanesulfonic anhydride both give ortho- addition new
products, but these products are trifluoromethanesulfonic and methanesulfonic addition phenol,
not fluorination phenol. In contrast to other fluoride reagents, however, deoxofluorination reagent
DAST (Dialkylamionosuflur trifluoride) generated a new fluorinated product which was proved
as fluorinated quinol not expecting ortho- fluorinated phenol (Scheme 2.1).

Scheme 2.1 Quinol with (Diethylamino)sulfur trifluoride DAST

While
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2.2.3 Deoxofluorination in Quinols7
Dialkylamionosuflur trifluoride (DAST) refers to deoxofluorination reagent, which is an easy to
handle fluorinating reagent useful for replacing hydroxyl with fluorine under very mild condition.
Deoxofluorination reagent attracts the hydroxyl group of the substrate on sulfur and the elimination
of one fluoride generates an alkoxyaminosulfur difluoride intermediate. The eliminated fluoride
ion will replace alkloxyaminosulfur difluoride to offer products, and this process can be S N1 or
SN2 nucleophilic pathway.8 In all those deoxofluorinating agents DAST and Deoxo-Fluor9 are the
most used.10

Table 2.1 DAST deoxofluorination in different solvent conditions a b
Entry

Solvent

Yield (%) c

1

Dichloromethane

30

2

1,2-dichloroethane

30

3

THF

Trace

4

Ethyl ether

Trace

5

1,4-dioxane

Trace

6

Acetonitrile

Trace

7

Toluene

No product

a

All reactions 1 mmol 4-methyl quinol and 1.2 mmol Dialkylamionosuflur trifluoride (DAST) were used. b All
reactions performed in ice bath (0 °C) for 2 hours. c Yield referring to isolated amount of product after column
chromatography.

To optimize the yield of fluorination quinol, different solvents are screened, such as THF, ethyl
ether, 1,4-dioxane, toluene, dichloromethane and 1,2-dichloromethane (Table 2.1). The best
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solvent is dichloromethane in 30% yield and 1,2-dichloromethane can be in the same yield (entries
1 and 2). THF, ethyl ether, and 1,4-dioxane offer trace or no product, because DAST may activate
O in ether to reduce reactivity (entries 3, 4 and 5). Acetonitrile in the same situation only can
provide a trace amount product (entry 6). Two new products are formed in toluene but 19F NMR
characterized that they are not fluoride compound (entry 7).
Table 2.2 DAST deoxofluorination from low to room temperature a
Entry

Temperature (°C)

Yield (%) b

1

20 (Room Temperature)

28

2

0 (Ice bath)

30

3

-46 (Dry Ice-Acetonitrile)

30

4

-78 (Dry Ice-Acetone) c

30

a

Reagents and conditions: 4-methyl quinol (1 mmol), DAST (1.2 mmol), dichloromethane 2 hours. b Yield referring
to isolated amount of product after column chromatography. c Reaction finished in 4 hours.

Further temperature screening with DAST revealed that 0 °C showed the best yield (Table 2.2).
DAST is well stable under room temperature (25 °C) or lower temperature condition, but side
product of deoxofluorination HF limited reaction in high-temperature condition. We noted that
room temperature (25 °C), ice bath (0 °C), dry ice-acetonitrile (-46 °C) and dry ice-acetone (-78
°C), reaction generated same level yield around 30% (entries 1 to 4). However, it was found under
room temperature (25 °C) reaction offered more side products and dry ice-acetone bath (-78 °C)
reaction time must extend to 4 hours (entries 3 and 4).

2.2.4 Experimental Scope of Quinols with DAST
Under the optimized reaction conditions using a wide range of quinols, which are readily
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prepared in one step from commercially available phenols 11, we explored the scope of quinol
fluorination synthesis with DAST. Representative results are summarized in Table 2.3, 2.4 and 2.5.

Table 2.3 Fluorination of one and multi substitutes quinol
Entry

Quinol

Product

Yield (%) a

Simple one substitute quinol

1

30
2.1

2.1a

2

42
2.2

2.2a

3

53
2.3

2.3a

4

61
2.4

2.4a
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Multi- Substitutes quinol

5

52
2.5

2.5a

6

51
2.6

2.6a

7

52
2.7

2.7a

8

52
2.8

2.8a

9

45
2.9

a Yield

2.9a

referring to isolated amount of product after column chromatography.

We began our investigation by treating one substitute quinol 2.1, 2.2, 2.3, and 2.4 with DAST.
The desired fluorination quinol product methyl 2.1a, ethyl 2.2a, propyl 2.3a, and isopropyl 2.4a
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revealed that there had been a slightly yield raised with bigger para-alky groups (entries 1 to 4).
We suspected the steric effect in deoxofluorination has hyperconjugation effect on the reactivity,
otherwise, alkyl substituents could increase new product forming by disrupted electrons on quinol.
Following the same strategy, multi-substitute results the ortho- and meta- dimethyl products 2.5a,
2.6a, both are in good yield around 50% (entries 5 and 6); 2,3,4 and 3,4,5 trimethyl quinol 2.7a,
2.8a can provide same yield range (entries 7 and 9).

Table 2.4 Fluorinated product of Cyclo- and Aryl- papa-quinol
Entry

Quinol

Fluorination Quinol

Yield (%) a

Cyclo- substitute

10

52
2.10

2.10a

11

51
2.11

2.11a

12

52
2.12

2.12a

88

13

52

2.13

2.13a
Aryl- substitute

14

48
2.14

2.14a

15

56

2.15

2.15a

16

96

2.16
a Yield

2.16a

referring to isolated amount of product after column chromatography.

Based on the successful synthesis of multi-substituted fluorination quinols, our strategy can be
extended to more complex quinol structures. All new compounds 2.10a, 2.11a, 2.12a, and 2.13a
are in a moderate yield of around 50% (entries 10 to 13). However, the main weakness was
observed that cyclopentane and cyclohexane quinol fluorination products 2.10a, 2.11a, 2.12a were
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very unstable at room temperature after vacuuming concentration. Although those products
collected from flash chromatography and vacuum in yellow oil, they turned into solid just in a few
hours. Fresh 2.10a, 2.11a, and 2.12a were characterized by 1H, 13C, and 19F NMR, otherwise, the
new solid compounds did not obtain any valuable NMR signal to prove their structure. The absence
of 19F proved they decomposed in hours after exposure in the air. For example, the original fresh
2.10a was isolated as clear yellow oil liquid but it quickly turned into blue solid after 6 h.
Considering 2.13a the cyclohexane derivative is a stable one and in 70% high yield, we proposed
the cyclo- substitute fluoride structure can cause ring structure extension or C-F bond shrinks bond
angle to decompose the structure. Unfortunately, aromatic substituted quinols offered fluorinated
results 2.14a and 2.15a which were facing the same problem, very unstable after concentrated,
decomposing in 3~4 hours (entries 14 and 15). However, 2.16a as the only solid fluorinate product,
it was not only the most stable one after isolated but also in the highest yield 96% (entry 16). We
assumed, there was no simple reason that can explain why these fluorinated quinols were more
unstable than others. We suspected phenyl- and bromophenyl- as electron-donating groups, which
can stabilize the cation after fluoride’s leaving, but the cyano group as an electron-withdrawing
makes it harder to generate the cation.
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Table 2.5 Fluorination of carbonyl and halide quinol
Entry

Quinol

Fluorination Quinol

Yield (%) a

Carbonyl substitute

17

88

2.17

2.17a

18

70

2.18

2.18a

19

51
2.19

2.19a

20

70
2.20

a Yield

2.20a

referring to isolated amount of product after column chromatography.

Next, we examined the reactions of carbonyl substituents. As shown in table 2.5, the other
carbonyl type 2.17a and 2.18a both are in excellent yield 70% to 88%, and excellent stability under
room temperature (entries 17 and 18). Halogenated substituents 2.19, 2.20 also performed well
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results, probably meta-bold is less hindered than 2.20 (entries 19 and 20).
2.2.5 Mechanism of DAST in Fluorination of Quinols
Even the DAST reaction in SN2 is mainstream, both retention and inversion of configuration
about carbon-containing the hydroxyl group have been noted with DAST reactions. 12 While
inversion appears unfavorable for steric reasons, the retention is observed. 13 Quinol is typically
impossible to undergo SN2 addition, so we proposed two possible mechanisms intermolecular and
intramolecular to explain our result. In the intermolecular mechanism, DAST and quinol would
process an SN1 addition to form para-substituted quinol. Next, DAST may active hydroxyl of
quinol to have deoxofluorination and leave quinol to have a cation. At the same time, fluorine as a
weak nucleophile attacked cation’s resonance structure to generate fluorination products (Scheme
2.2).
Scheme 2.2 Intermolecular mechanism for fluorinated quinol by DAST

Otherwise, in the intramolecular mechanism, after DAST activated the quinol to form the new
complex, one fluorine transferred to para position and removed the hydroxyl group with the residue
of DAST (Scheme 2.3). When we assumed carbon cation only existed in the intermolecular
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process and not in the intramolecular process, there would be two types of results if we introduced
extra halogenated source. When extra fluoride was added, the rate of the fluorinated product was
likely to increase; when another halogenated source was added, the reaction probably generated a
new corresponding halogenated product. The findings of Table 2.6 suggested that introducing
extra fluoride sources failed to raise up the rate and the yield (entries1, 2 and 3). Even merely trace
amount fluorinated product was offered when 2 equivalent TBAF was added. Turning to new
halogenated source addition, no new halogenated product was observed by reaction with TBACl,
TBABr, and TBAI (entries 4, 5 and 6).
Scheme 2.3 Intramolecular SN1 mechanism for fluorinated quinol by DAST

Table 2.6 Introduced halogen sources to DAST reaction
Entry

Halogen Source

Equiv.

Result a

1

TBAF

10%

30%

2

TBAF

1

10%

3

TBAF

2

Trace

4

TBACl

1

No new co-product

5

TBABr

1

No new co-product

6

TBAI

1

No new co-product

a Yield

referring to isolated amount of product after column chromatography.
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2.2.6 Conclusion
In summary, following chlorination of quinol strategy, we have demonstrated an unexpected
deoxofluorination of quinol mediated by DAST. Since the difference of nucleophilic ability
between

chlorine

and

flourine,

deoxofluorination

of

quinol

generated

fluorinated

cyclohexadienone, instead of para-phenol. Most of quinols can use this new path to generate
fluorinated quinols, however, the electron withdrawing substitute quinols can offer more stable
products than other quinols structure. With fluorinated cyclohexadienone in hand, our next targets
are 1) increase yield and stability of all cyclohexadienone structures 2) develop a directly path to
approach fluorinated phenol basing on this strategy. As one mild and simple way to approach
fluorinated cyclohexadienone, which can be an important middle structure in organic synthesis, it
will offer a more successful way in fluorine synthesis.
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Experimental Section
General Consideration
Anhydrous CH2Cl2 was distilled from CaH2 under an atmosphere of argon. All reagents were
purchased from commercial sources or synthesized using literature methods. 1H and 13C NMR
spectra were recorded on BRUKE 500 MHz spectrometers; 1H and 13C NMR chemical shifts (δ
values) were reported in ppm from downfield using internal standard TMS (1H NMR) or CDCl3
(13C NMR), respectively. All mass spectra were run by the Hunter College Mass Spectrometry
Facility and taken on an Agilent 6520A Q-TOF using electrospray ionization. All infrared spectra
were taken on a Thermo Nicolet IR100 spectrometer. Column chromatography was performed
over silica with a porosity of 60 Å and a particle size of 40-63 µm. Coupling constants (J) are
reported in units of hertz (Hz). The following abbreviations are used to describe multiplets: s
(singlet), d (doublet), t (triplet), q (quartet), quint (quintuplet), sept (septet), m (multiplet), br
(broad).

Preparation of Quinols
Quinols are made from the oxidation of phenols by phenyliodoso diacetate (PIDA) following
general procedures of and verified by 1H and 13C NMR.
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DAST deoxofluorination of quinols

4-fluoro-4-methylcyclohexa-2,5-dienone
2.1a: quinol 2.1 (1 mmol, 124 mg) was dissolved in DCM (3 ml) at 0 °C. DAST (1.2 mmol, 0.17
ml) was injected slowly. After the addition of DAST, the reaction mixture was stirred at this
temperature for 1 hour. The reaction was then quenched with water (2ml) and the solvent was
extracted with DCM (3*2 ml) then dried over Na2SO4. After filtration, then extract was
concentrated, and the residue was purified by chromatography (EtOAc/Hexane 1/10). Yield: 65
mg, 30%.
1

H NMR (500 MHz, CDCl3) δ 6.94 (q, J=5 Hz, 2 H) 6.23 (d, J=10 Hz, 2 H) 1.67 (d, J=20 Hz, 3

H); 13C NMR (500 MHz, CDCl3) δ 184.75, 146.78, 128.52, 87.21, 25.81; 19F (400 MHz, CDCl3)
δ -145.82.
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4-ethyl-4-fluorocyclohexa-2,5-dienone
2.2a: quinol 2.2 (1 mmol, 138 mg) was dissolved in DCM (3 ml) at 0 °C. DAST (1.2 mmol, 0.17
ml) was injected slowly. After the addition of DAST, the reaction mixture was stirred at this
temperature for 1 hour. The reaction was then quenched with water (2 ml) and the solvent was
extracted with DCM (3*2 ml) then dried over Na2SO4. After filtration, then extract was
concentrated, and the residue was purified by chromatography (EtOAc/Hexane 1/10). Yield: 58
mg, 42%
1

H NMR (500 MHz, CDCl3) δ 6.90 (q, J=5 Hz, 2 H) 6.29 (d, J=10 Hz, 2 H) 2.00 (m, J=8 Hz, 2 H),

0.97 (t, J=7.5 Hz, 3 H); 13C NMR (500 MHz, CDCl3) δ 185.05, 145.75, 129.64, 90.29, 31.82, 7.69;
19

F (400 MHz, CDCl3) δ -150.39.
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4-fluoro-4-propylcyclohexa-2,5-dienone
2.3a: quinol 2.3 (1 mmol, 153 mg) was dissolved in DCM (3 ml) at 0 °C. DAST (1.2 mmol, 0.17
ml) was injected slowly. After addition of DAST, the reaction mixture was stirred at this
temperature for 2 hours. The reaction was then quenched with water (2 ml) and the solvent was
extracted with DCM (3*2 ml) then dried over Na2SO4. After filtration, then extract was
concentrated, and the residue was purified by chromatography (EtOAc/Hexane 1/10). Yield: 81
mg, 53%
1

H NMR (500 MHz, CDCl3) δ 6.91 (q, J=7.5 Hz, 2 H) 6.27 (d, J=10 Hz, 2 H) 1.92 (m, J=8 Hz, 2

H), 1.41 (t, J=7 Hz 2 H), 0.99 (t, J=7 Hz, 3 H); 13C NMR (500 MHz, CDCl3) δ 185.05, 146.21,
129.35, 89.75, 40.91, 16.86, 14.16; 19F (400 MHz, CDCl3) δ -148.99.
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4-fluoro-4-isopropylcyclohexa-2,5-dienone
2.4a: quinol 2.4 (1 mmol, 153 mg) was dissolved in DCM (3 ml) at 0 °C. DAST (1.2 mmol, 0.17
ml) was injected slowly. After the addition of DAST, the reaction mixture was stirred at this
temperature for 2 hours. The reaction was then quenched with water (2 ml) and the solvent was
extracted with DCM (3*2 ml) then dried over Na2SO4. After filtration, then extract was
concentrated, and the residue was purified by chromatography (EtOAc/Hexane 1/10). Yield: 92
mg, 60%
1

H NMR (500 MHz, CDCl3) δ 6.78 (d, J=2 Hz 1 H), 6.72 (d, J=1 Hz, 1 H), 6.71(s, J=1 Hz, 1 H),

3.08 (m, J=1.5 Hz 1 H), 1.16(d, J=9 Hz 3 H);

13

C NMR (500 MHz, CDCl3) δ 188.22, 155.00,

144.97, 137.10, 135.95, 130.38, 127.96, 26.81, 21.36, 16.7; 19F (400 MHz, CDCl3) δ -152.93.
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4-fluoro-2,4-dimethylcyclohexa-2,5-dienone
2.5a: quinol 2.5 (1 mmol, 138 mg) was dissolved in DCM (3 ml) at 0 °C. DAST (1.2 mmol, 0.17
ml) was injected slowly. After the addition of DAST, the reaction mixture was stirred at this
temperature for 2 hours. The reaction was then quenched with water (2 ml) and the solvent was
extracted with DCM (3*2 ml) then dried over Na2SO4. After filtration, then extract was
concentrated, and the residue was purified by chromatography (EtOAc/Hexane 1/10). Yield: 72
mg, 52%
1

H NMR (500 MHz, CDCl3) δ 6.89 (m, J=2.5 Hz, 1 H) 6.69 (m, J=1.5 Hz, 1 H) 6.21(d, J=1 Hz, 1

H), 1.93 (q, J=1 Hz, 3 H), 1.64 (d, J=20 Hz 2 H); 13C NMR (500 MHz, CDCl3) δ 185.46, 146.49,
142.09, 135.43, 128.48, 87.57; 19F (400 MHz, CDCl3) δ -144.81.
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4-fluoro-3,4-dimethylcyclohexa-2,5-dienone
2.6a: quinol 2.6 (1 mmol, 138 mg) was dissolved in DCM (3 ml) at 0 °C. DAST (1.2 mmol, 0.17
ml) was injected slowly. After addition of DAST, the reaction mixture was stirred at this
temperature for 2 hours. The reaction was then quenched with water (2 ml) and the solvent was
extracted with DCM (3*2 ml) then dried over Na2SO4. After filtration, then extract was
concentrated, and the residue was purified by chromatography (EtOAc/Hexane 1/10). Yield:70
mg, 51%
1

H NMR (500 MHz, CDCl3) δ 6.74(q, J=7 Hz, 1 H), 5.99(d, J=1 Hz, 1 H), 5.85(d, J=1 Hz, 1 H),

1.91(s, 3 H), 1.45(d, J=16 Hz, 3 H); 13C NMR (500 MHz, CDCl3) δ 185.16, 157.27, 147.41, 128.09,
126.34, 89.19, 25.11, 17.51δ; 19F (400 MHz, CDCl3) δ -151.35.
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4-fluoro-2,4,6-trimethylcyclohexa-2,5-dienone
2.7a: quinol 2.7 (1 mmol, 152 mg) was dissolved in DCM (3 ml) at 0 °C. DAST (1.2 mmol, 0.17
ml) was injected slowly. After the addition of DAST, the reaction mixture was stirred at this
temperature for 2 hours. The reaction was then quenched with water (2 ml) and the solvent was
extracted with DCM (3*2 ml) then dried over Na2SO4. After filtration, then extract was
concentrated, and the residue was purified by chromatography (EtOAc/Hexane 1/10). Yield: 79
mg, 52%
H NMR (500 MHz, CDCl3) δ 6.65 (d, J=6.5 Hz, 2 H), 1.92 (s, 6 H), 1.61 (d, J=20 Hz, 3 H); 13C

1

NMR (500 MHz, CDCl3) δ 186.22, 142.61, 141.37 87.66, 86.41, 25.61, 16.30;
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F (400 MHz,

CDCl3) δ -146.51.
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4-fluoro-3,4,5-trimethylcyclohexa-2,5-dienone
2.8a: quinol 2.8 (1 mmol, 152 mg) was dissolved in DCM (3 ml) at 0 °C. DAST (1.2 mmol, 0.17
ml) was injected slowly. After the addition of DAST, the reaction mixture was stirred at this
temperature for 2 hours. The reaction was then quenched with water (2 ml) and the solvent was
extracted with DCM (3*2 ml) then dried over Na2SO4. After filtration, then extract was
concentrated, and the residue was purified by chromatography (EtOAc/Hexane 1/10). Yield: 79
mg, 52%
H NMR (500 MHz, CDCl3) δ 6.01 (d, J=0.5 Hz 2 H), 2.11 (s, 6 H), 1.65 (d, J=17.5 Hz 3 H); 13C

1

NMR (500 MHz, CDCl3) δ 185.10, 158.2, 126.17, 91.65, 25.04, 17.41; 19F (400 MHz, CDCl3) δ 158.05.
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4-fluoro-4-isopropyl-3-methylcyclohexa-2,5-dienone
2.9a: quinol 2.9 (1 mmol, 166 mg) was dissolved in DCM (3 ml) at 0 °C. DAST (1.2 mmol, 0.17
ml) was injected slowly. After the addition of DAST, the reaction mixture was stirred at this
temperature for 2 hours. The reaction was then quenched with water (2 ml) and the solvent was
extracted with DCM (3*2 ml) then dried over Na2SO4. After filtration, then extract was
concentrated, and the residue was purified by chromatography (EtOAc/Hexane 1/10). Yield: 75
mg, 45%.
1

H NMR (500 MHz, CDCl3) δ 6.93 (q, J=7.5 Hz 1 H), 6.32 (q, J=2 Hz, 1 H), 6.12(d, J=1.5 Hz, 1

H), 2.38 (m, J=4.5 Hz 1 H), 1.18(d, J=9 Hz 3 H), 0.73(d, J=9 Hz, 3 H);

13

C NMR (500 MHz,

CDCl3) δ 185.13, 156.98, 143.51, 130.64, 127.96, 94.78, 34.52, 17.49, 16.74, 16.40; 19F (400 MHz,
CDCl3) δ -158.05.
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4-fluoro-2,3-dihydro-1H-inden-5(7aH)-one
2.10a: quinol 2.10 (1 mmol, 152 mg) was dissolved in DCM (3 ml) at 0 °C. DAST (1.2 mmol, 0.17
ml) was injected slowly. After the addition of DAST, the reaction mixture was stirred at this
temperature for 4 hours. The reaction was then quenched with water (2 ml) and the solvent was
extracted with DCM (3*2 ml) then dried over Na2SO4. After filtration, then extract was
concentrated, and the residue was purified by chromatography (EtOAc/Hexane 1/10). Yield: 79
mg, 52%.
H NMR (500 MHz, CDCl3) δ 6.92 (q, J=4.5 Hz, 1 H), 6.16 (m, J= 10Hz, 1 H), 6.02 (s, 1 H), 2.90

1

(m, J=3 Hz, 2 H), 2.58 (m, J=4 Hz, 1 H), 2.32 (m, J=4 Hz, 2 H ), 2.04 (m, J=3 Hz, 1 H), 1.78 (m,
J=3 Hz, 1H); 13C NMR (500 MHz, CDCl3) δ 185.88, 162.79, 140.70, 131.00, 123.84, 93.33, 35.06,
28.19, 21.41; 19F (400 MHz, CDCl3) δ -158.05.
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4-fluoro-5,6,7,8-tetrahydronaphthalen-2(4aH)-one
2.11a: quinol 2.11 (1 mmol, 164 mg) was dissolved in DCM (3 ml) at 0 °C. DAST (1.2 mmol, 0.17
ml) was injected slowly. After the addition of DAST, the reaction mixture was stirred at this
temperature for 4 hours. The reaction was then quenched with water (2 ml) and the solvent was
extracted with DCM (3*2 ml) then dried over Na2SO4. After filtration, then extract was
concentrated, and the residue was purified by chromatography (EtOAc/Hexane 1/10). Yield: 83
mg, 51%.
1

H NMR (500 MHz, CDCl3) δ 6.85(q, J=4 Hz, 1 H), 6.24(d, J=10 Hz, 1 H), 6.07(s, 1 H), 2.67(m,

10H); 13C NMR (500 MHz, CDCl3) δ 185.81, 159.07, 146.16, 129.39, 124.01, 38.40, 32.08, 27.42,
20.54; 19F (400 MHz, CDCl3) δ -156.61.
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4-fluoro-7-methyl-2,3-dihydro-1H-inden-4(7H)-one
2.12a: quinol 2.12 (1 mmol, 164 mg) was dissolved in DCM (3 ml) at 0 °C. DAST (1.2 mmol, 0.17
ml) was injected slowly. After the addition of DAST, the reaction mixture was stirred at this
temperature for 4 hours. The reaction was then quenched with water (2 ml) and the solvent was
extracted with DCM (3*2 ml) then dried over Na2SO4. After filtration, then extract was
concentrated, and the residue was purified by chromatography (EtOAc/Hexane 1/10).
1

H NMR (500 MHz, CDCl3) δ 6.87(d, J=10 Hz, 1 H), 6.11(d, J=10 Hz, 1 H), 2.90(m, J=1.5 Hz, 1

H), 2.73(m, J=1.5 Hz, 3H), 2.06(m, J=1 Hz, 4H); 13C NMR (500 MHz, CDCl3) δ 184.81, 164.31,
152.42, 136.79, 127.67, 68.11, 32.37, 29.62, 25.53, 21.55; 19F (400MHz, CDCl3) δ 150.31.
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cyclohexyl-4-fluorocyclohexa-2,5-dienone
2.13a: quinol 2.13 (1 mmol, 192 mg) was dissolved in DCM (3 ml) at 0 °C. DAST (1.2 mmol,
0.17 ml) was injected slowly. After the addition of DAST, the reaction mixture was stirred at this
temperature for 4 hours. The reaction was then quenched with water (2 ml) and the solvent was
extracted with DCM (3*2 ml) then dried over Na2SO4. After filtration, then extract was
concentrated, and the residue was purified by chromatography (EtOAc/Hexane 1/10). Yield: 100
mg, 52%.
1

H NMR (500 MHz, CDCl3) δ 6.87(m, J=6.5 Hz, 2 H), 6.27(d, J=10 Hz, 2 H), 1.85(m, J=10 Hz, 6

H), 1.27(m, J=10 Hz, 6 H) ; 13C NMR (500 MHz, CDCl3) δ 185.26, 145.45, 129.89, 91.85, 45.82,
26.87, 26.00; 19F (400 MHz, CDCl3) δ -153.91.
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4-fluoro-4-phenylcyclohexa-2,5-dienone
2.14a: quinol 2.14 (1 mmol, 186 mg) was dissolved in DCM (3 ml) at 0 °C. DAST (1.2 mmol,
0.17 ml) was injected slowly. After the addition of DAST, the reaction mixture was stirred at this
temperature for 4 hours. The reaction was then quenched with water (2 ml) and the solvent was
extracted with DCM (3*2 ml) then dried over Na2SO4. After filtration, then extract was
concentrated, and the residue was purified by chromatography (EtOAc/Hexane 1/10). Yield: 89
mg, 48%.
1

H NMR (500 MHz, CDCl3) δ 7.44(m, J=6.5 Hz, 5 H), 6.96(q, J=6 Hz, 2 H), 6.32(d, J=8.5, 2 H);

13

C NMR (500 MHz, CDCl3) δ 185.08, 145.70, 136.75, 129.10, 128.24, 124.78, 89.47; 19F (400

MHz, CDCl3) δ -152.47.
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4-(4-bromophenyl)-4-fluorocyclohexa-2,5-dienone
2.15a: quinol 2.15 (1 mmol, 265 mg) was dissolved in DCM (3 ml) at 0 °C. DAST (1.2 mmol, 0.17
ml) was injected slowly. After the addition of DAST, the reaction mixture was stirred at this
temperature for 4 hours. The reaction was then quenched with water (2 ml) and the solvent was
extracted with DCM (3*2 ml) then dried over Na2SO4. After filtration, then extract was
concentrated, and the residue was purified by chromatography (EtOAc/Hexane 1/10). Yield: 148
mg, 56%.
1

H NMR (500 MHz, CDCl3) δ 7.56(d, J=7 Hz, 2 H), 7.29(t, J=7 Hz, 2 H), 6.92(q, J=7 Hz, 2 H),

6.33(d, J=10 Hz, 2 H); 13C NMR (500 MHz, CDCl3) δ 184.75, 145.04, 135.90, 132.29, 128.53,
126.53, 123.36, 89.16; 19F (400 MHz, CDCl3) δ -152.56.

111

4-(1-fluoro-4-oxocyclohexa-2,5-dienyl) benzonitrile
2.16a: quinol 2.16 (1 mmol, 211 mg) was dissolved in DCM (3 ml) at 0 °C. DAST (1.2 mmol, 0.17
ml) was injected slowly. After the addition of DAST, the reaction mixture was stirred at this
temperature for 4 hours. The reaction was then quenched with water (2 ml) and the solvent was
extracted with DCM (3*2 ml) then dried over Na2SO4. After filtration, then extract was
concentrated, and the residue was purified by chromatography (EtOAc/Hexane 1/10). Yield: 202
mg, 96%.
1

H NMR (500 MHz, CDCl3) δ 7.75(d, J=7 Hz, 2 H), 7.55(d, J=7.5 Hz, 2 H), 6.92(q, J=7 Hz, 2 H),

6.40(d, J=10 Hz, 2 H); 13C NMR (500 MHz, CDCl3) δ 184.43, 144.27, 141.91, 132.94, 129.12,
125.68, 118.06, 113.17, 89.28; 19F (400 MHz, CDCl3) δ -153.90.
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methyl 2-(1-fluoro-4-oxocyclohexa-2,5-dienyl) acetate
2.17a: quinol 2.17 (1 mmol, 182 mg) was dissolved in DCM (3 ml) at 0 °C. DAST (1.2 mmol, 0.17
ml) was injected slowly. After the addition of DAST, the reaction mixture was stirred at this
temperature for 6 hours. The reaction was then quenched with water (2 ml) and the solvent was
extracted with DCM (3*2 ml) then dried over Na2SO4. After filtration, then extract was
concentrated, and the residue was purified by chromatography (EtOAc/Hexane 1/10). Yield: 160
mg, 88%.
1

H NMR (500 MHz, CDCl3) δ 7.06(q, J=6.6 Hz, 2 H), 6.26(t, J=8Hz, 2 H), 3.69(s, 3 H), 2.91(d,

J=18Hz, 2 H); 13C NMR (500MHz, CDCl3) δ 184.31, 167.70, 144.29, 129.67, 86.24, 77.27, 52.26,
43.62; 19F (400 MHz, CDCl3) δ -150.07.
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4-fluoro-4-(2-oxopropyl) cyclohexa-2,5-dienone
2.18a: quinol 2.18 (1 mmol, 166 mg) was dissolved in DCM (3 ml) at 0 °C. DAST (1.2 mmol,
0.17 ml) was injected slowly. After the addition of DAST, the reaction mixture was stirred at this
temperature for 6 hours. The reaction was then quenched with water (2 ml) and the solvent was
extracted with DCM (3*2 ml) then dried over Na2SO4. After filtration, then extract was
concentrated, and the residue was purified by chromatography (EtOAc/Hexane 1/10). Yield: 116
mg, 70%.
1

H NMR (500 MHz, CDCl3) δ 7.00(q, J=10 Hz, 2 H), 6.20(d, J=10 Hz, 1 H), 2.92(d, J=20 Hz, 2

H), 2.19(s, 3 H); 13C NMR (500 MHz, CDCl3) δ 202.64, 184.58, 144.30, 129.46, 86.91, 85.59,
50.93, 32.23; 19F (400 MHz, CDCl3) δ -151.43.
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3-chloro-4-fluoro-4-methylcyclohexa-2,5-dienone
2.19a: quinol 2.19 (1 mmol, 158 mg) was dissolved in DCM (3 ml) at 0 °C. DAST (1.2 mmol, 0.17
ml) was injected slowly. After the addition of DAST, the reaction mixture was stirred at this
temperature for 2 hours. The reaction was then quenched with water (2 ml) and the solvent was
extracted with DCM (3*2 ml) then dried over Na2SO4. After filtration, then extract was
concentrated, and the residue was purified by chromatography (EtOAc/Hexane 1/10). Yield: 80
mg, 51%.
1

H NMR (500 MHz, CDCl3) δ 6.99(q, J=10 Hz, 1 H), 6.45(s, 1 H), 6.27(d, J=10 Hz, 1 H), 1.79(d,

J=11 Hz, 3 H);

13

C NMR (500 MHz, CDCl3) δ 183.32, 153.87, 145.95, 128.16, 127.77, 88.11,

24.85; 19F (400 MHz, CDCl3) δ -146.51.
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2-bromo-4-fluoro-4-methylcyclohexa-2,5-dienone
2.20a: quinol 2.20 (1 mmol, 201 mg) was dissolved in DCM (3 ml) at 0 °C. DAST (1.2 mmol, 0.17
ml) was injected slowly. After the addition of DAST, the reaction mixture was stirred at this
temperature for 2 hours. The reaction was then quenched with water (2 ml) and the solvent was
extracted with DCM (3*2 ml) then dried over Na2SO4. After filtration, then extract was
concentrated, and the residue was purified by chromatography (EtOAc/Hexane 1/10). Yield: 140
mg, 70%.
1

H NMR (500 MHz, CDCl3) δ 7.19 (s, 1 H), 6.86 (m, J=7.2 Hz, 1 H), 6.20 (t, J=8 Hz, 1 H), 1.46

(s, 3 H); 3C NMR (500 MHz, CDCl3) δ 172.34, 141.78, 121.85, 120.07, 83.82, 20. 18; 19F (400
MHz, CDCl3) δ -144.12.
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Chapter 3 Study of Total Synthesis of Anticancer Agent
Strongylophorine-26
3.1 Introduction of Strongylophorine Family
The discovery of natural marine products increased significantly in previous years.1 Sponges,
as filter-feeding marine invertebrates, host a variety of microorganisms not only reflect the
microbial communities present in surrounding seawater but also appear to constitute a more
specialized association between sponge hosts and microbial associates. 2,3 Irrespective of the nature
of sponge-fungi associations, sponge-derived fungal cultures has repeatedly been shown to be
interesting sources of new bioactive secondary metabolites previously unknown from terrestrial
strains of the same species.4 In 1978, three novel meroditerpenoids, strongylophorine‐1, 2, 3 have
been isolated from the sponge Strongylophora durissima from Papua New Guinea by Braekman.5
After that, people found many other members of strongylophorine family from sponges. 6 The
strongylophorines are a family of meroditerpenoids which are a terpenoid subclass delivered from
hybrid biosynthetic pathways that fuse terpene substructures with polyketide or alkaloid
components.7 Studies of strongylophorines prove meroditerpenoid display potency of molecular
pharmacology and diverse biological activity.8 Strongylophorine-2, -3, -8 are inhibitors to HIF-1
and -8 also owns neuroprotective effects; strongylophorine-26 (STP-26) is an inhibitor of tumor
cell invasion.
Tumor growth and metastasis cause tumor cells to invade surrounding tissues. In the invading
process, activated vascular endothelial cells and generated new capillaries to irrigate tumors and
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provide conduits for metastatic spread.9 A fundamental aspect of invasion and angiogenesis in cell
migration, which is a dynamic process that involves regulated cyclical changes in cell shape, cell
adhesion, and the cytoskeleton.10, 11 Rho-GTPases are important regulators involved in tumor
invasion and angiogenesis.12, 13, 14 Rho, a subgroup of the Rho-GTPases, inducing the formation of
stress fibers and mature focal adhesions, are overexpressed in some invasive cancers. 15
Strongylophorine-26 induced a decrease in actin stress fibers to cause a transient activation of the
GTPase Rho and was treatment with the Rho inhibitor abrogated the invasive activity.16

Fig 3.1 Strongylophorines family

3.1

3.2

3.3

Strongylophorine-1

Strongylophorine-2

Strongylophorine-8

3.4 Strongylophorine-26(STP-26)

178

3.2 Synthesis of Strongylophorine
Even strongylophorines family has special latent power in pharmaceutical research, the
challenge structure and unclarified biological activities limited the synthesis of this family. The
syntheses of the strongylophorines have been rarely reported. Poulsen’s group first reported semi
synthesis of strongylophorine-2 in 2016 and they developed a catalytic oxidative quinone
heterofunctionalization method to finish strongylophorine-26 in 2018. Recently, Dethe and Sau
published a new method for synthesis of Strongylophorines 2 and 9.
3.2.1 Professor Poulsen Strategy Toward Strongylophorine-217
Poulsen’s group reported a concise route to the Strongylophorines (Scheme 3.1). The key steps
are novel iron (III)-mediated rearrangement–cyclization cascade and a directed photochemical sp3
C-H δ-lactonization. They were aware of the potential power semisynthetic method starting from
labdane diterpene isocupressic acid 3.5 which was a major constituent of the bark and needles of
the Ponderosa pine tree. Isocupressic acid 3.5 linked with the desired 4-methoxylphenol to offer
corresponding allyl ether derivative 3.6. The cascade transformation through the exposure of allyl
ether 3.6 to Lewis acid FeCl3 was able to generate benzyl-protected STR-1 3.7. Debenzylation of
3.7 delivered STR-1 3.1 and then conversed to amide 3.8. Based on Barton photochemical
lactonization, amide 3.8 closed lactone bridge and accessed provided 1, 2-Didehydro-STR-9 3.9.
Diastereoselective hydrogenation of 3.9 under heterogeneous conditions proceeded STP-9 3.10.
Moreover, demethylation of STR-9 3.10 could offer STR-2 3.2.
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Scheme 3.1 Poulsen’s strategy toward strongylophorine-2

3.5

3.6

3.7

3.1 (STR-1)

3.8

3.9
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3.10 (STP-9)

3.2 (STP-2)

ADDP=1,1’-(Azodicarbonyl)-dipiperidine, HATU=1-[Bis(dimethylamino)methylene]-1H-1,2,3-triazolo[4,5-b]
pyridinium 3-oxid
TMS=trimethylsilyl

hexafluorophosphate,

HOAt=1-Hydroxy-7-azabenzotriazole,

LTA=Lead(IV)acetate,

3.2.2 Synthesis of Strongylophorine-26 by Catalytic Oxidative Quinone Method18
Based on previously successful synthesis of strongylophorine-2, Poulsen’s group discussed the
conversion of 3.2 (STR-2) to 3.4 (STR-26) by C6-methoxylation. In their path, to prepare 3.4 from
3.2, oxidative opening of the 4’-phenoxy-chromane ring and installation of the methoxy
substituent are required. However, the p-benzoquione 3.11 can be easily generated, there was a
lack of a general method for methoxylation of the p-benzoquione. Inspired by the method for the
aerobic coupling of phenols to o-quinones of Lumb and the evaluation of other methods,19-21
Poulsen’s group developed a new metal-catalyzed p-benzoquinone alkoxylation method (Scheme
3.2).
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Scheme 3.2 Mechanism of p-benzoquinone methoxylation

Scheme 3.3 Construction of STR-26

3.2 (STR-2)

3.11

182

3.4

3.12
3.4/3.12=1.3/1
Total 61% in two steps

Following their method for the functionalization of p-quinones, they constructed a path of 3.4
with Chromane-oxidation of 3.2 using NaIO4·SiO2 afforded the quinone 3.11. Immediately
subjected 3.11 to methoxylation conditions using Co(OAc)2 in methanol at reflux for 44 hours.
These two steps reaction could generate a mixture of 3.4 and the tentative 5’-regioisomer (3.12) in
61% yield (Scheme 3.3).

3.2.3 Dethe and Sau’s Strategy Toward Strongylophorine-2 and 922
Recently, Dethe and Sau published their total synthesis work of Strongylophorines -2 (3.2) and
-9 (3.10) (Scheme 3.4). Their work began with selective ketalization and alkylation of the Wieland-
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Miescher ketone derivative 3.13 to generate alkylated product 3.14. In the first key step, 3.14
successfully constructed the tricyclic terpenoid building block enone 3.15 by Robinson
annulation.23 Following a few steps of functional groups interconversion, enone 3.15 transferred
to tricyclic alcohol 3.19. The next step was another key element in the route, and they employed
Suarez photocatalysis condition using PI(OAc)2/I2 for sp3 C-H activation on the axial methyl of
3.19.24 Since the product of Suarez photocatalysis was unstable, directly following by Pinnick
oxidation and TBAF mediated lactonization on the intermedia offered requisite lactone 3.20.
Replacement of the enone at the -OTBS position of 3.20 using deprotection, 1-C Witting
olefination, and allylic oxidation could offer enone 3.22. With the required aromatic fragment 3.27
and the terpene enone 3.22 in hand, two parts were coupled to generate Michael adduct 3.23. To
incorporate the remaining group in the terpene part, the ketone was covered to an exomethylene
by Witting olefination to produce 3.24. After debenzylation and cyclization, 3.24 transferred to
3.10 (STP-9), which could convert to 3.2 (STP-2) by demethylation.
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Scheme 3.4 Dethe and Sau strategy toward Strongylophorine-2 and 9
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3.23

3.24

3.25

3.10 (STP-9)

3.26

3.2 (STP-2)

3.27
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3.3 Study of Total Synthesis of Anticancer Agent Strongylophorine-26
3.3.1 Brief Route to Strongylophorine-26
The route benefits from the use of known tricyclic precursors, and a highly convergent plan in
which advanced tetracyclic and quinone precursors are coupled at a late stage (Scheme 3.5).
Precursor 3.28 is followed by Snider radical cyclization to close tricyclic ring, then following
mCPBA epoxidation to generate precursor 3.29.25 Selective strategy can open epoxy ring of 3.29
to approach diol product which would be protected by 2-methoxyprop-1-ene to afford 3.30.26
Further reducing ketone on the tricyclic ring with NaBH 4 and introducing ammonia could form
amide 3.31. Remote C-H functionalization in 3.31 could be affected to afford 3.32 by Barton’s Niodoamide method.27 Conversion of the primary alcohol 3.32 to the halide fragment then followed
by Negishi coupling would provide 3.33.28 Debenzylation followed by DDQ oxidation would
afford STP-26 3.4.

Scheme 3.5 Brief route to Strongylophorine-26

3.28

3.29
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3.30

3.31

3.32

3.33

3.4

3.3.2 Synthesis of precursor 3.28 from Farnesol 3.34
Scheme 3.6 Farnesol 3.34 to precursor 3.28

3.34

3.35
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3.36

3.37

3.38

3.28

3.39

3.29

3.40

The synthesis commenced with preparing the precursor 3.28 (Scheme 3.6). Our synthetic
sequence began with natural 15-carbon acyclic sesquiterpene alcohol Farnesol 3.34, which was
protected by acetic anhydride to offer farnesyl acetate 3.35. Farnesyl acetate 3.35 was subjected to
the conditions for Sharpless oxidation to approach allylic alcohol 3.36. Upon treatment with
lithium bromide, allylic alcohol 3.36 could provide bromide 3.37 in good yield 83%. Exposure of
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3.37 to 3.41, sodium hydride, and n-Butyllithium, resulted in diterpenoid 3.38. Diterpenoid 3.38
could also be protected by acetic anhydride to generate precursor 3.28. We employed the Mn-Cucatalyzed cascade radical reaction developed by Snider to prepare tricyclic dieterpenoid 3.39. In
our opinion, by using mCPBA or DMSO oxidation reagent, epoxide 3.40 will be in hand.

3.3.3 The study of Sharpless Oxidation
Exposed olefin with selenium dioxide would approach allylic alcohols. However, the main
weakness of this oxidation method is SeO2 is a high toxic reagent. Following Sharpless’s study
mixed olefins with tert-Butyl hydroperoxide in the presence of catalytic (1.5-2%) SeO2, would
produce allylic alcohols in yields comparable with, or better than, those obtained with
stoichiometric SeO2 alone.29 Another problem with this approach is that it fails to long-chain
olefins. It had been observed long-chain olefins only generated 20% or lower yield allylic alcohol.
A significant reason for the low yield was that selective reactivity of SeO 2 was reduced due to a
longer alkyl chain length.30 Shibuya demonstrated that the replacement of salicylic acid with
formic acid led to offer allyl formate in high yield.31 Kitagawa et al. reported without salicylic acid
and shorting reaction time could increase allylic alcohol productivity in Sharpless reaction. 32
However, those theories did not fully resolve the low activity of long-chain olefins. We wished to
have an opportunity to modify the Sharpless strategy for long-chain olefin by avoiding the use of
excess SeO2 and reducing side products like aldehyde, to convert the farnesyl acetate to the desired
allylic substituent (Table 3.1).
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Table 3.1 Modify of Sharpless reaction
Entry

SeO2

Solvent

T (oC)

Additive a

Yield (%) c

1

1%

Dichloromethane

25

tBuOOH,

18

Salicylic
acid
2

1%

Dichloroethane

25

tBuOOH,

18

Salicylic
acid
3

1%

Toluene

25

tBuOOH,

Trace

Salicylic
acid
4

1%

THF

25

tBuOOH,

None

Salicylic
acid
5

1%

Dioxane

25

tBuOOH,

None

Salicylic
acid
6

2

Dioxane

60

Formic acidb

None

a. Entry 1 to 5, tBuOOH (2.5 equiv.) and salicylic acid (10 mol%) were added. b. Formic acid (2 equiv.) was
employed. c Isolated yields.
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Oxidation of farnesyl acetate 3.34 with SeO2 in the presence of tert-Butyl hydroperoxide readily
yield allylic alcohol 3.35 in 41%. Application of commonly used Sharpless oxidation condition,
which involved SeO2 reactivity decrease, and side over-oxidation aldehyde product, resulted in
very slow oxidation of 3.34 providing low yields of 18%. Attempt to optimize this reaction by
Shibuya condition was not successful (entry 6). Similarly, merely little improvement in yield (2%)
was observed when salicylic acid was removed as described in an alternative procedure by
Kitagawa.
Scheme 3.7 Temperature and reaction time relationship for Sharpless oxidation
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Table 3.2 Temperature and reaction time relationship for Sharpless oxidation a
Temperature=25 °C
Entry

Time (h)

Yield (%) b

Recycled Farnesyl acetate (%) c

1

2

18

36

3

4

18

36

3

8

12

34

Temperature=0 °C
4

2

Trace

90

5

4

12

80

6

8

21

66

a. SeO2 (1 mol%), tBuOOH (2.5 equiv.), and salicylic acid (10 mol%) were employed in Sharpless oxidation. b.
c Isolated yields.

To improve the reactivity of the Sharpless procedure, we sought to figure out the best reaction
conditions. Except for dichloromethane and dichloroethane, other solvents could not offer cheerful
results. Production of allylic alcohol 3.35 peaked at 2 hours, after that the graph showed that there
had been a steady decline. Moreover, at 0 °C oxidation process was slower, and the continual
growth of 3.35 arrived maximum yield at 8 hours. Both room temperature (25 °C) and 0 °C shared
similar yield, but 0 °C is different from room temperature (25 °C) in the generation of less aldehyde
(Scheme 3.8 and Table 3.2). In the case of Sharpless oxidation, merely depending on adjusting
reaction temperature and time resulted in little improvement in yield. To overcome activity
decreasing of SeO2, we proposed an extra addition of SeO2 can optimize oxidation (Table 3.3).
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Although the extra addition of SeO2 probably rises the formation of side products, aldehyde level
can remain steady with low reaction temperature. The yield of the desired product sharply
increased with an extra SeO2 addition and rose to a high point and peaked in 10% SeO2. However,
with more addition of SeO2, the yield marked decrease, 16% yield with 20% SeO2 and trace yield
with 30% SeO2.

Table 3.3 Difference of SeO2 using in Sharpless oxidation a
Entry

SeO2 (mol%)

Yield (%) b

Recovered Farnesyl acetate (%) c

1

1

22

66

2

10

37

34

3

20

16

34

4

30

12

0

a. tBuOOH (2.5 equiv.), and salicylic acid (10 mol%) were employed. b. c Isolated yields.

Compared to original literature precedent for the Sharpless reaction, although the excess
amount of SeO2 would boost over oxidation products, the reaction could set up under an ice bath
(0 °C) condition and extend reaction time to 8 hours. With 10% SeO2 in dichloromethane, isolated
allylic alcohol yield can arrive at 37% and recycled farnesyl acetate at 34%.
3.3.4 Conclusion
In conclusion, opening the epoxide ring of 3.29 is the next step and it would offer diol structure.
Because of the stereospecificity of diol, selecting the right path is a challenge. However, this long-
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lasting effort gave us the occasion of developing new relevant methodologies of synthesis. The
study of the Sharpless oxidation strategy allows us to optimize conditions for complex starting
materials. The new synthetic application for all strongylophorine-26 is currently pursued in our
laboratory and will be reported in due course.
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Supporting information
General Consideration
Anhydrous CH2Cl2 was distilled from CaH2 under an atmosphere of argon. All reagents were
purchased from commercial sources or synthesized using literature methods. 1H and

13

C NMR

spectra were recorded on BRUKE 500 MHz spectrometers; 1H and 13C NMR chemical shifts (δ
values) were reported in ppm from downfield using internal standard TMS (1H NMR) or CDCl3
(13C NMR), respectively. All mass spectra were run by the Hunter College Mass Spectrometry
Facility and taken on an Agilent 6520A Q-TOF using electrospray ionization. All infrared spectra
were taken on a Thermo Nicolet IR100 spectrometer. Column chromatography was performed
over silica with a porosity of 60 Å and a particle size of 40-63 µm. Coupling constants (J) are
reported in units of hertz (Hz). The following abbreviations are used to describe multiplets: s
(singlet), d (doublet), t (triplet), q (quartet), quint (quintuplet), sept (septet), m (multiplet), br
(broad).

3.35 (2E,6Z)-3,7,11-trimethyldodeca-2,6,10-trienyl acetate
25 g 3.34 was dissolved in 40 ml dry pyridine, then slowly added 40 ml Ac2O in four potions over
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a 15 min period. The mixture was stirred for 6h after that poured the mixture into 250 g ice. Added
400ml water, extracted with five 100ml portions of hexane. The organic layer washed with 2*50
ml water, 5% sulfuric acid and saturated NaHCO3 solution. Drying by Na2SO4. The compound
3.35 is yellow oil.
Yield: 96% (30.3 g) 1HNMR: δ=5.38 (t, J=7.1 Hz, 1 H), 5.12 (d, J=4.4 Hz, 2 H), 4.61 (d, J=7.1 Hz,
2 H), 2.19 (m, 11 H), 1.72 (d, J=, 13 Hz, 6 H), 1.62 (s, 6 H) ppm; 13CNMR: δ=171.20, 142.35,
135.49, 131.37, 124.30, 123.61, 118.21, 61.43, 39.70, 26.71, 26.17, 25.72, 21.10, 17.71, 16.49,
16.03 ppm. HRMS m/z calculated for C17H28O2 [M+H+] 265.2123, found 265.2149.

3.36 (2E,6Z,10E)-12-hydroxy-3,7,11-trimethyldodeca-2,6,10-trienyl acetate
SeO2 (0.26 g, 0.23 mmol), 40 ml CH2Cl2 and 6.8 ml 90% tert-Butyl hydroperoxide was mixed and
stirred under room temperature (25 oC) for half hour, and then transferred the mixture into ice bath
(0 °C) condition. 3.35 (6 g, 22.7 mmol) was introduced into the mixture solution in 20 min and the
whole mixture was stirred in the ice bath (0 °C) for 8 h. The reaction was quenched by saturated
20 ml Na2S2O3 solution, then extracted by 3*10 ml CH2Cl2, washed by saturated NaHCO3 solution
and dried by Na2SO4. The compound 3.36 is yellow oil.
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Yield: 37% (2.4 g) 1HNMR: δ=5.39 (m, J=1 Hz, 2 H), 5.11 (t, J=6.5 Hz, 1 H), 4.59 (d, J=7 Hz, 2
H), 3.99 (s, 1 H), 2.12 (m, 10 H), 1.70 (m, 11 H), 1.26 (s, 1 H) ppm; 13CNMR: δ=171.24, 142.26,
135.11, 134.74, 125.99, 123.91, 118.27, 69.02, 61.43, 39.49, 39.26, 26.15, 26.12, 25.75, 21.10,
16.49, 16.02, 13.72 ppm. HRMS m/z calculated for C17H28O3 [M+H+] 281.2072, found 281.2064.

3.37 (2E,6Z,10E)-12-bromo-3,7,11-trimethyldodeca-2,6,10-trienyl acetate
3.36 (7.6 g, 27 mmol) was dissolved in 120 ml dry THF and introduced the flask under the
acetonitrile dry ice bath (-46 °C). MsCl (methane sulfonyl chloride, 4.0 g, 2.73 ml, 35 mmol) and
triethylamine (5.5 g, 7.52 ml, 54 mmol) were added over 5 min, and the solution would be stirred
in a cold bath for 45 min. Dropwise added LiBr (9.4 g, 108 mmol) in 20ml THF solution into the
mixture of 3.36, then stirred for 1 h. The reaction was quenched by 200 ml cold water and extracted
by 4*60 ml ethyl ether. The organic layer was dried by Na2SO4. The compound 3.37 is yellow oil.
Yield: 83% (7.7 g) 1HNMR:δ=5.51 (t, J=7 Hz, 1 H), 5.28 (t, J=7 Hz, 1 H), 5.04(t, J=5.5 Hz, 2 H),
4.52 (d, J=7 Hz, 2 H), 2.05 (m, 11 H), 1.68 (m, 10 H) ppm; 13CNMR: δ=171.20, 142.23, 134.68,
131.20, 124.24, 118.27, 61.42, 41.92, 39.46, 38.74, 26.82, 26.14, 21.11, 16.49, 15.99, 14.68 ppm.
HRMS m/z calculated for C17H27BrO2 [M+H+] 344.1174, found 344.1185.
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3.38 (6E,10Z,14E)-ethyl 16-hydroxy-2,6,10,14-tetramethyl-3-oxohexadeca-6,10,14-trienoate
Ethyl 2-methyl-3-oxobutanoate 3.40 (7.84 g, 54.5 mmol) was added via a syringe to a suspension
of NaH (2.4 g, 54.4 mol) and HMPA (2 ml) in 120 ml dry THF at 0 oC under N2 protection with
stirring over 45 min. After addition, the reaction became viscous, then added another 2 ml HMPA
and 80 ml THF and stirring were continued for 1 h. 22 ml n-Butyllithium in hexane was added
dropwise by syringe over 1 h and continued to be stirring for 1 h at 0 oC. Dissolved 3.37 (4.67 g,
13.6 mmol) in 20 ml THF and dropwise added into the flask over 30 min and stirring another 1 h.
50 ml 10% HCl solution was added to quench the reaction and followed by addition of 30 ml
CH2Cl2. The organic layer was washed with 100 ml water and 100 ml brine, dried by Na2SO4. The
compound 3.38 is yellow oil.
Yield: 88% (4.4 g) 1HNMR:δ=5.45 (t, J=7 Hz, 1 H), 5.13 (d, J=6.5 Hz, 2 H), 4.23 (m, J=7 Hz, 4
H), 3.56 (m, J=7 Hz, 1 H), 2.71 (m, J=7.5 Hz, 2 H), 2.14 (t, 7,5 Hz, 2 H), 2.08 (m, J=7 Hz, 8 H),
1.70 (s, 3 H), 1.61 (s, 5 H), 1.35 (d, J=7 Hz, 3 H), 1.30 (t, J=7.5 Hz, 3 H) ppm; 13CNMR: δ=205.73,
170.63, 139.72, 135.16, 133.33, 125.02, 123.39, 123.36, 61.38, 59.42, 52.91, 40.19, 39.63, 33.30,
30.48, 26.92, 25.90, 16.30, 14.11, 12.18 ppm. HRMS m/z calculated for C22H36O4 [M+H+]
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365.2647, found 365.2661.

3.28 (6E,10E,14E)-ethyl 16-acetoxy-2,6,10,14-tetramethyl-3-oxohexadeca-6,10,14-trienoate
3.38 (3 g, 8 mmol) was dissolved in 4 ml dry pyridine, then slowly added 1.5 ml Ac2O in four
potions over a 15 min period. The mixture was stirred for 6 h after that poured the mixture into 30
g ice. Added 60 ml water, extracted with five 30 ml portions of hexane. The organic layer washed
with 2*10 ml water, 5% sulfuric acid and saturated NaHCO 3 solution. Drying by Na2SO4. The
compound 3.28 is yellow oil.
Yield: 92% (3 g) 1HNMR: δ=5.42 (t, J=7 Hz, 1 H), 5.11 (q, J=6.5 Hz, 2 H), 4.20 (q, J=7.5 Hz, 2
H), 4.16 (d, J=7.5 Hz, 2 H), 3.53 (q, J=7 Hz, 1 H), 2.68 (m, J=7.5 Hz, 2 H), 2.26 (t, J=8 Hz, 2 H),
2.11 (m, 8 H), 1.67 (s, 3 H), 1.58 (s, 5 H), 1.33 (d, J=7 Hz, 3 H), 1.26 (t, J=7 Hz, 5H) ppm; 13CNMR:
δ=205.73, 170.63, 139.73, 135.16, 133.33, 125.02, 123.93, 123.36, 61.35, 59.42, 52.91, 40.16,
39.53, 33.30, 29.72, 26.56, 26.26, 16.30, 16.06, 14.12, 12.81, 12.78 ppm. HRMS m/z calculated
for C24H38O5 [M+H+] 407.2753, found 407.2747.
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3.29 (1R,4aR,8aR)-ethyl 8-(acetoxymethyl)-1,4a,8a-trimethyl-7-methylene-2oxotetradecahydrophenanthrene-1-carboxylate
Methanol (10 ml) poured into 100 ml round bottom flask and bubbled by nitrogen for 30min to
exile oxygen. Mn(OAc)32H2O (1.4 g, 4.93 mmol) and Cu(OAc)2H2O (502 mg, 2.46 mmol) was
dissolved in Methanol and kept stirring for 10min. Dissolved 3.28 (1 g, 2.46 mmol) in 15 ml
methanol and dropwise added into the flask over 30 min and stirring another 4 h. Open to the air
to quench the reaction and the organic layer was washed with 20 ml water then flowed by 3*15 ml
CH2Cl2 and 10 ml brine, Dried by Na2SO4. The compound 3.29 is yellow oil.
Yield: 21% (210 mg) 1HNRM: δ=7.09 (d, J=1 Hz, 1 H), 7.055(d, J=8 Hz, 1 H), 4.19 (m, J=3.5 Hz,
2 H), 3.03 (m, J=6.5 Hz, 1 H), 2.81 (dd, J=6 Hz, J=6.5 Hz, 1 H), 2.47 (m, J=1.5 Hz, 2 H), 2.19 (m,
J=4 Hz, 3 H), 1.87 (m, J=3.5 Hz, 2 H), 1.81 (m, J=7 Hz, 1 H), 1.78 (q, J=7 Hz, 2 H), 1.66 (m. 14
H), 1.05 (s, 3 H) ppm; 13CNMR: δ=208.51, 173.56, 136.94, 136.76, 135.15, 119.46, 61.07, 57.81,
57.57, 54.96, 40.60, 40.58, 37.60, 36.47, 33.99, 25.76, 20.90, 20.61, 20.54, 18.76, 13.93, 13.68
ppm. HRMS m/z calculated for C24H36O5 [M+H+] 405.2596, found 405.2610.
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